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Abstract 
Poornima Kotha Lakshmi Narayan Ph.D. Biomedical Sciences Ph.D. Program. 
Wright State University, 2014. The regulation of the eight-exon isoform of the 
Coxsackievirus and Adenovirus Receptor (CAREx8) and its biological relevance 
The airway epithelium poses a formidable barrier for the entry of pathogenic 
viruses due to the formation of tight junctions between adjacent epithelial cells. 
The coxsackievirus and adenovirus receptor (CAR), a member of the Ig 
superfamily of cell junction adhesion proteins, is the primary receptor for 
adenovirus entry and infection. As a result of alternative splicing, two 
transmembrane isoforms of CAR are generated. While the seven-exon isoform of 
CAR (CAREx7) is hidden on the basolateral surface of polarized epithelia, the eight-
exon isoform of CAR (CAREx8) localizes within the sub-apical region and at the air-
exposed apical surface. Apical localization of CAREx8 makes it accessible to 
invading adenovirus entering the lumen of the airway and able to facilitate viral 
entry into the epithelium. Previous studies have shown that Interleukin-8 (IL-8), a 
proinflammatory cytokine and a neutrophil chemoattractant, increases the 
susceptibility of the airway epithelium to adenoviral infection. I hypothesized that 
the apical CAREx8 protein expression level and localization are responsible for the 
susceptibility of a polarized epithelium to viral infection. Moreover, I hypothesized 
that CAREx8 expression is tightly regulated by mediators of IL-8 signaling and the 
endogenous function CAREx8 is to tether neutrophils at the apical surface of the 
polarized epithelium. Finally, I hypothesized that adenovirus
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has co-opted CAREx8 and neutrophil transmigration to enhance infection of the 
polarized epithelium.  
Consistent with these hypotheses, I demonstrate that IL-8 increases the 
expression and the apical localization of CAREx8 in polarized airway epithelial cells. 
In addition, IL-8 differentially activates AKT/S6K and inactivates GSK3β to 
augment the protein synthesis of CAREx8. Increased CAREx8 is able to mediate 
increased neutrophil binding at the apical surface of the epithelium that is 
completely abolished by competition with CAR-binding adenovirus fiber-knob. 
Finally, I also demonstrate that neutrophils adhering to the epithelial apical surface 
are able to promote adenoviral infection. Taken together, these data suggest that 
adenovirus has evolved to co-opt the host innate-immune response to the 
inflammation caused by molecules within inhaled droplets, pre-existing 
inflammation, or even adenovirus itself, in order to gain entry into the polarized 
epithelium by inducing the increased expression of endogenous apically localized 
CAREx8.  
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Chapter 1: Introduction: 
Our world is full of pathogens that prey on nutrient-rich organisms. All mammals, 
including humans, have evolved a complex set of innate barriers to prevent 
infection. The lung is one of the organs that comes into direct contact with the 
external environment and is a major portal of entry. The epithelium of the lung 
provides a first line of defense and is constantly exposed to inhaled pathogens that 
are normally cleared without causing inflammation or damage to the lung. 
However, there are times when susceptibility to infection is elevated. Much 
remains to be understood about factors that predispose us to the infection and how 
pathogens crack the epithelial barrier to gain entry into the host. 
1.1. Junctional adhesion complex (JAC)  
Epithelial cells line the mucosal surface of the airway. These are polarized cells 
with the apical surface facing the lumen of the airway tract and the basal surface 
facing the interstitium. One of the essential functions of the epithelium is to form a 
barrier thereby separating the harsh outside environment from the more fragile 
inside. Epithelial cells prevent the paracellular movement of inhaled particles into 
the interstitium. Likewise, it also prevents the loss of essential components into the 
airway lumen. This barrier function is accomplished by the JAC, which is 
composed of transmembrane and cytoplasmic tight junction proteins (TJ) and 
adherens junction (AJ) proteins (Figure 1A). Tight junction proteins are located at 
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the apico-lateral surface of the epithelial cells and form a zipper like structure that 
seals the space between the epithelial cells. Tight junction proteins include 
transmembrane proteins, cytoplasmic plaque proteins and cytoskeletal proteins 
[1]. Claudins are an example of tight junction transmembrane proteins that form 
homodimers with those on adjacent cells and form tight junction strands. Other 
transmembrane proteins including occludin and tricellulin are localized within or in 
close proximity to the tight junction strands. The cytoplasmic domains of both 
claudin and occludin bind to tight junction cytoplamic plaque proteins, which 
include: Zona occludin 1, 2 and 3 (ZO-1, ZO-2 and ZO-3) (Figure 1B) [2]. These 
are structurally related proteins that contain several functional domains (three PDZ 
domains, one SH3 domain and one GUK domain) through which they can interact 
with actin thereby linking the tight junctions to the actin cytoskeleton. In addition, 
tight junction proteins include junctional adhesion molecules (JAMs) and the 
coxsackievirus and adenovirus receptor (CAR), which belong to the 
immunoglobulin (Ig) superfamily of proteins. Although CAR is often classified as a 
tight junction protein, CAR is on the basolateral side of the tight junction and mainly 
overlaps with adherens junction proteins, such as epithelial cadherin (E-cadherin) 
[3, 4].  
Adherens junctions are found beneath the tight junction seal (Figure 1B). 
These junctions serve to hold adjacent epithelial cells together as opposed to 
completely sealing the space between cells. Adherens junction proteins are 
comprised of the cadherin family of transmembrane proteins, Ig-like proteins and 
cytoplasmic plaque proteins such as α/β/δ-catenins [1]. The extracellular domain 
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of E-cadherin possesses five repetitive sub-domains called the extracellular 
cadherin or the ‘EC’ domain [5]. It is through these sub-domains that cadherins 
form homophillic interactions with those on the adjacent cells in a calcium-
dependent manner. Treating the cells with calcium chelators, such as EDTA, 
disrupts the cadherin-cadherin interaction by removing calcium and allowing the 
junctions to fall apart. Subjacent to adherens junction are the desmosomal 
junctions, which aid in anchoring the neighboring cells. Similar to tight and 
adherens junction proteins, desmosomal junctions are also composed of 
transmembrane proteins and cytoplasmic plaque proteins. Transmembrane 
proteins include, JAM-C, desmoglein and desmocollin, while the plaque proteins 
include desmoplakin, plakophillin and γ-catenin. The cytoplasmic plaque proteins 
are connected to the intermediate filaments [1]. Therefore, the epithelial barrier 
integrity is maintained by the combination of these junctional proteins. Alteration in 
the expression and localization of these junctional proteins will tremendously 
impact the transepithelial resistance and permeability of the epithelial barrier.   
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       Adapted from Chin et al., 2007 
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Figure 1: Schematic of polarized epithelial cells. The apical surface of the cells faces 
the air-exposed airway lumen and the basolateral (basal) surface faces the interstitium. 
The cells are held together by the junctional adhesion complex (JAC) which is composed 
of apico-lateral tight junction (TJ) and basolateral adherens junction (AJ) proteins. B. A 
schematic of epithelial cells showing the different components of TJ and AJ. TJ proteins 
include transmembrane proteins such as claudin and occludin and cytoplasmic 
scaffolding proteins such as zona occludins (ZO-1 and -2). The adherens junction 
proteins include transmembrane proteins such as coxsackievirus and adenovirus 
receptor (CAR) and E-cadherin.   
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1.2. Regulation of adhesion proteins:  
The expression and localization of various epithelial cell surface adhesion proteins 
are tightly regulated and are responsive to external stimuli, such as inflammation. 
For example, exposure of airway epithelial cells to tissue necrosis factor alpha 
(TNF-α) in combination with interferon gamma (IFN downregulates the gene 
expression and redistributes the tight junction proteins JAM and ZO-1 in airway 
epithelia. Likewise, in endothelial cells, gene expression and localization of CAR 
is downregulated in response to INF- and TNF-α. These cytokines also increase 
the permeability of both epithelial and the endothelial cells [6, 7]. As a result, the 
barrier integrity and the epithelial cell permeability is compromised by exposure to 
cytokines [7]. Tumor growth factor beta (TGF-β) and TNF-α negatively regulate the 
gene expression of occludin and claudin in testis. IFN- disrupts the epithelial 
barrier integrity by promoting macropinocytosis of the tight junction proteins 
occludin, claudin-1, and JAM-A [8, 9]. Intercellular adhesion molecule-1 (ICAM-1) 
relocates to the apical surface of intestinal epithelial cells in response to IFN- [10]. 
Interleukin-8 (IL-8), a proinflammatory cytokine relocalizes αvβ3 integrin and CAR 
at the epithelial apical surface. All these examples provide evidence for a profound 
effect of cytokines on the junctional proteins.  
1.3. Junctional proteins as viral receptors:  
The port of entry for many viruses has numerous barriers. When entering the 
respiratory tract, they first confront the mucus layer, above the apical surface of 
the epithelium that is constantly being swept out of the respiratory tract. Once 
through the mucus, the virus must find its receptor on the epithelium. While many 
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viruses utilize apical proteins as receptors for entry and infection (for example: 
influenza virus uses α 2-6 linked-sialic acid, rhinovirus uses ICAM-1), other viruses 
utilize junctional proteins as their primary receptor. For example: reovirus uses 
JAM-A [11], hepatitis C requires claudin and occludin [12], the measles virus 
depends on nectin-4, an AJ protein, as its primary receptor [13], and the coxsackie 
B virus along with most adenovirus serotypes utilize CAR as a primary receptor 
[14, 15]. The viruses that have adapted to utilize epithelial apical proteins as 
primary receptors are expected to find their receptors and bind to the apical surface 
of epithelial cells to initiate infection rather easily. However, if a virus has its primary 
receptor sequestered below the TJ, accessing the primary receptor to initiate an 
airborne infection appears to be more complicated and challenging. For a long 
time, it was believed that a mechanical break in the epithelial junctions was 
required to allow the virus to access its basolaterally localized primary receptor. 
Although this continues to serve as a potential mechanism for viral infection, recent 
studies have shown that viruses are astute in breaking into the intact epithelium. 
For example, Coxsackie B virus binds to DAF, an apical protein, which facilitates 
the translocation of the virus to the tight junction where it can interact with CAR 
and gain entry into the host cell [16]. Reovirus binds sialic acid at the apical surface 
which then mediates the binding of the virus to its primary receptor, JAM-A, 
allowing the virus to enter its host [17]. However, recent studies suggest that viral 
receptors once believed to be sequestered below the tight junctions might have 
alternatively spliced isoforms that can localize to the apical surface, facilitating the 
initial viral entry from the apical surface.  Our lab has shown that adenovirus binds 
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to an alternatively spliced version of CAR (CAREx8), which localizes to the apical 
surface, allowing adenovirus to gain entry into the airway epithelia from the air 
exposed apical surface [18-20].  
1.4. Adenovirus 
Adenovirus is a non-enveloped virus that is icosohedral in shape. Adenovirus is 
typically 80 nm in size and encloses a double stranded DNA genome. Over 50 
human adenovirus types have been identified and are categorized into groups A 
through G. Adenoviruses most commonly cause mild and self-limiting upper and 
lower respiratory tract infections. However, in military recruits, pediatric patients, 
and in immunocompromised individuals, adenoviruses can cause fatal respiratory 
distress. Apart from respiratory infections, adenovirus can also cause 
conjunctivitis, gastroenteritis, and cystitis [21]. The virion has 12 triangular faces 
and 12 vertices. While the triangular faces are composed of a total of 240 hexons, 
the vertices are composed of pentons. From each penton base arises a trimeric 
fiberknob (FK) [21-23]. In order to infect, adenovirus first attaches to the host cell 
by binding to its receptor on the target cell via FK. The FKs of all adenovirus 
species, except group B, bind and utilize CAR as their primary receptor [15, 21, 
23-27]. Several other important co-receptors, such as MHC class I [28], sialic acid 
[29], and coagulation factor X [30], have been described. Subsequently, the RGD 
motif on the Ad penton base binds to the αvβ3 or αvβ5 integrins, which function as 
co-receptors. Binding to these integrins activates downstream signaling, which 
facilitates clathrin-mediated endocytosis of the virus. Alternatively, the virus is also 
endocytosed through macropinocytosis or other non-clathrin mechanisms [31, 32].  
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After internalization, as the endosomes acidify, the Ad-FK dissociates from 
the capsid leading to a partial uncoating of the virus and release of protein VI. 
Protein VI aids in the lysis of the endosomal membrane and thereby facilitates viral 
escape into the cytoplasm [33]. Once in the cytoplasm, the virus interacts with 
dynein, a molecular motor protein, via the viral capsid protein, hexon, and is 
translocated along the microtubules to the microtubule organizing center (MTOC) 
near the nucleus [33]. From here the virus enters the nucleus via a mechanism 
that is not yet clearly understood.  
1.5. Coxsackie and adenovirus receptor (CAR):  
The first step for efficient infection by adenovirus is the attachment to the host cell 
and this is facilitated by the receptor on the host cell. As the name suggests, CAR 
was first identified as a receptor for both Coxsackie B viruses and most serotypes 
of adenovirus [15, 34-36]. It was shown that CAR is essential for the development 
of the heart, as knocking out CAR in mice proved embryonically lethal [37]. It was 
shown that CAR is required for the efficient development of both the heart and the 
lymphatic system [37, 38]. CAR is expressed in a variety of organs including the 
heart, brain, pancreas, lung, kidney, liver, small intestine, colon, and prostrate [37, 
39, 40]. In polarized epithelia CAR is important for the maintenance of the epithelial 
barrier integrity [4]  
CAR is a transmembrane protein that belongs to the immunoglobulin 
superfamily of proteins with two extracellular Ig-like domains. The most distal Ig-
like domain, D1, mediates homophilic adhesion between CAR proteins on adjacent 
cells, heterophilic adhesion with adenovirus fiber knob and junction-adhesion 
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molecule like protein (JAML) found on leukocytes, such as neutrophils, all at an 
overlapping interface [7, 41] (Figure 2). The binding affinities of the different CAR 
interaction are listed in Table 1. CAR binds to Ad FK with nearly a 1000 fold greater 
affinity than with CAR itself. Therefore, adenovirus FK can outcompete CAR-CAR 
interactions. This was evident from viral egress studies that demonstrated that 
once adenovirus has infected the airway epithelium, FK is released into the 
basolateral extracellular space and breaks the CAR-CAR interactions and 
epithelial tight junctions to allow the virus to escape to the apical surface [4].  
The gene for CAR, located on human chromosome 21 and named CXADR, 
consists of 8 separate exons. Alternative splicing of the exons results in 2 
transcripts that encode 2 transmembrane isoforms. Both of the protein isoforms 
have identical extracellular and transmembrane domains, differing only in the 
extreme cytoplasmic carboxy-termini. The most abundant isoform originates from 
the splicing of the first seven exons of CAR (CAREx7) (Figure 3A). CAREx7 localizes 
at the basolateral surface of polarized epithelial cells and is inaccessible to 
invading pathogens from the apical surface (Figure 3B) [4, 18-20, 42]. CAREx7 
plays a key role in the maintenance of the epithelial barrier integrity via the 
formation of homodimers between adjacent epithelial cells. This isoform is also 
responsible for adenovirus egress after viral infection. The intact airway epithelium 
is largely resistant to CAR-mediated adenoviral infection because the major 
isoform is sequestered beneath the tight junction. The alternate transmembrane 
isoform is derived from mRNA splicing within the seventh exon to the eighth exon 
(CAREx8). This splice event leads to a unique 13 aa c-terminus in CAREx8 that 
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replaces 26 aa unique to the c-terminus found in the CAREx7 isoform (Figure 3A). 
CAREx8 resides at the subapical/apical surface of the airway epithelium [18-20]. 
This apical localization creates a logical explanation as to how adenovirus infection 
can be initiated from the apical surface into intact epithelium [18]. It is important to 
understand the regulation of CAREx8 because any stimulus that either augments 
or decreases the levels of apically exposed CAREx8 is likely to be crucial for 
modulating the susceptibility of the airway to viral infection.  
The heterophilic interaction of CAR with JAML on leukocytes is important for 
neutrophil transepithelial migration during inflammation and infection (explained in 
detail in the next section).  
 
 
  
10 
 
Figure 2: Schematic showing different CAR interactions. A) CAR interaction with 
adenovirus fiber knob at the CAR D1 domain. B) Hemophilic CAR-CAR interaction occurs 
between adjacent epithelial cells to hold them together. C) Heterophilic CAR-JAML 
interaction occurs between epithelial cells and neutrophils. Note that all three interactions 
occur at the same overlapping interface on CAR 
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Figure 3: Transmembrane isoforms of CAR and their localization in polarized airway 
epithelia. A) Schematic of CAREx7 and CAREx8 that shows the extracellular region 
comprising the D1 and the D2 domains, the transmembrane region embedded into a lipid 
raft within the plasma membrane, and the C-terminus extending into the cytoplasm. The 
CAREx7 isoform has 26 aa that are unique to this isoform and CAREx8 has 13 unique aa 
due to alternative splicing from a cryptic splice site within the 7th exon of the gene for CAR, 
CXADR. B) Immunofluorescence staining of the two transmembrane isoforms of CAR 
(green) and Zo-1 (red) in primary airway epithelial cells.  CAREx7 (top panel) localizes at 
the basolateral surface and CAREx8 (bottom panel) localizes at the sub-apical and the 
apical surface (arrow). 
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1.6. Junctional adhesion molecule like (JAML) 
Moog-Lutz et al., 2003, discovered JAML, a novel member of JAM family of 
proteins [43]. JAML is a transmembrane protein with extracellular, 
transmembrane, and intracellular domains. JAML belongs to the immunoglobulin 
superfamily as it contains two extracellular immunogloubulin (Ig) like domains 
called the D1 (membrane distal) and the D2 (membrane proximal) domains. One 
of the intriguing features of JAML is that, unlike other JAMs, it is exclusively 
expressed on the surface of leukocytes including neutrophils, macrophages, 
monocytes, γδ T-cells, and to a lesser extent on other human T lymphocytes. 
JAML interacts with CAR on epithelial cells and therefore is also called AMICA-1 
(Adhesion molecule interacting with CAR antigen-1) [43-47]. The crystal structure 
of the JAML-CAR receptor-ligand pair reveals that the membrane distal D1 domain 
of JAML interacts with the membrane distal D1 domain of CAR [47].  
As mentioned earlier, CAR normally forms homodimers by binding to 
another CAR molecule on an adjacent cell. This interface where one CAR 
molecule binds to another CAR molecule overlaps with the binding sites of both 
adenovirus FK and JAML. One CAR molecule can only bind to one molecule of 
CAR, JAML, or adenovirus at any one time. About 16 of 18 CAR amino acid 
residues that are involved in JAML binding overlap with the adenovirus FK binding 
site. The binding affinities of heterophilic and homophilic CAR interactions are in 
the order of CAR-adenovirus FK > CAR-JAML > CAR-CAR [24, 47, 48] (Table 1). 
Therefore, binding to adenovirus fiber knob will inhibit CAR binding to JAML. 
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Table 1: Binding affinities of CAR-mediated interactions. 
 
  
Type of CAR interaction Binding affinity (KD) reference 
CAR-CAR  16 µM [24] 
CAR- JAML 5 µM [47] 
CAR- Ad fiber knob 14 nM [48] 
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1.7. Transepithelial migration:  
In addition to serving as a barrier to the paracellular movement of large and small 
molecules, JAC also regulates the migration of polymorphonuclear leukocytes 
(PMNs), including neutrophils, across the epithelium. Neutrophils are the first 
leukocytes to arrive at the site of infection. Therefore, neutrophil transepithelial 
migration is crucial for clearing pathogenic infection. Defective neutrophil 
transmigration is seen in diseases such as leukocyte adhesion deficiency type-1 
(LAD-1) and causes increased susceptibility to pathogens [49, 50]. In contrast, 
excessive and unregulated neutrophil infiltration can cause tissue damage and is 
the characteristic of a variety of inflammatory diseases such as inflammatory bowel 
disease in the gastrointestinal system, chronic obstructive pulmonary disease 
(COPD) and cystic fibrosis (CF) in the airway.  
 Upon stimulation, PMNs exit the vascular circulation, by migrating through 
the paracellular space found between adjacent endothelial cells (a process called 
transendothelial migration), and reach the connective tissue. PMNs further migrate 
through the paracellular space between the epithelial cells (transepithelial 
migration) before encountering the pathogen in the lumen of the airway. While 
PMN transmigration through the vascular endothelium has been extensively 
studied, transmigration through the epithelial barrier is not well understood. In 
addition, there are striking differences between the PMN transendothelial and 
transepithelial migration. For example: 1) Transendothelial migration occurs in the 
apical to basal direction, whereas transepithelial migration occurs from the basal 
surface to the apical surface. 2) The initial PMN-endothelial interaction occurs at 
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the endothelial apical surface. In contrast, the initial PMN-epithelial interaction 
occurs at the epithelial basal surface. 3) During transendothelial migration, PMNs 
migrate a relatively short distance, a few microns, as opposed to > 20 m distance 
migrated during transepithelial migration [10, 51]. 4) The adhesive interactions 
occurring during the transendothelial migration are quite different from those 
involved in transepithelial migration. For instance, PMN transendothelial migration 
is dependent on the PMN CD11b/CD18 and CD11a/CD18 protein interaction with 
the endothelial cell surface ICAM-1 protein. Although CD11b/CD18 is important for 
transepithelial migration, CD11a/CD18 has not been shown to be involved in 
transepithelial migration.  Moreover, upon stimulation with IFN-, ICAM-1 
expression is localized to the epithelial apical surface and therefore is not 
accessible for infiltrating neutrophils. Once migrated ICAM-1 can however mediate 
adhesion of transmigrated neutrophils to the apical surface [10, 52, 53].  
In vitro studies using model human epithelial cell lines have demonstrated 
that high-density PMN transepithelial migration disrupts the barrier integrity, 
whereas the low-density PMN migration does not [51, 54]. Low density PMN 
migration occurs during normal immune surveillance in a tightly regulated manner 
without compromising the barrier integrity. However, upon pathogenic invasion, 
intense PMN (including neutrophils) transmigration ensues. Epithelial cells sense 
the invading microbe through pathogen recognition and subsequently release a 
number of chemokines, which in turn recruit PMNs. During transepithelial 
migration, PMNs have to cross a relatively long paracellular path before they can 
reach the tight junction seal. In order to reach the apical surface, PMNs breach the 
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epithelial barrier either by loosening or disrupting the complex of junctional proteins 
supporting the epithelial barrier. The compromised junctional barrier is however, 
reformed upon the resolution of the infection. Our knowledge on neutrophil 
transepithelial migration is based on studies conducted in intestinal epithelia. 
There is currently a gap in the literature regarding this process in airway epithelia 
[51]. Although, some of the studies in the intestinal epithelium can be translated to 
the airway epithelium, one must recognize the important anatomical differences 
between these two systems. The upper airway is comprised of ciliated columnar 
epithelial cells, while the lower airway is comprised of squamous and cuboidal 
epithelial cells. On the other hand, the intestinal epithelia are non-ciliated cells and 
are modified into finger-like projections called microvilli. 
Neutrophil transepithelial migration is a complex process that involves 
multiple interactions between the neutrophil and epithelial cells (Figure 4) [1, 55] 
and is not well understood. The process of neutrophil transepithelial migration can 
be broadly divided into early events and late events. During the early events, the 
physical interaction between the neutrophils and the basal surface of the epithelial 
cells is sufficient to increase the permeability of the junctional barrier. This event 
occurs prior to neutrophil transmigration. The increase in permeability occurs as a 
result of signaling that, without grossly affecting the expression and the localization 
of the junctional proteins, contracts the actomyosin ring that encircles the 
cytoplasmic side of epithelial cells. During the late events, which are characterized 
by the actual migration of neutrophils, remodeling of the junctional proteins is 
observed. Thus, the physical interaction between the epithelial cells and the 
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infiltrating neutrophils is essential during both the early and late events of epithelial 
transmigration [54].  
Neutrophil transepithelial migration begins with the adhesion of the neutrophil 
proteins CD11b/CD18 to a yet unidentified ligand at the epithelial basal surface. 
There are differences between neutrophil migration in the gastrointestinal system 
and in the lung. For example, While, CD11b/CD18 is required for neutrophil 
transepithelial migration in the gastrointestinal system, this process can occur in 
the absence of CD11b/CD18 in lung epithelial tissue [1]. After initial attachment to 
the basal surface of the epithelium, neutrophils migrate through the paracellular 
space. This migration process is a stepwise process that involves various protein-
protein interactions, some of which are as follows: 1) activation of epithelial 
protease-activated receptors 1 and 2 (PAR 1 & 2) by a family of PMN membrane 
bound proteases called the serposidins [56]; 2) interaction between epithelial 
CD47 and the PMN-expressed signal regulatory protein α (SIRP-α) [1]; 3) epithelial 
JAM-C binding to CD11b on neutrophils [57]; 4) interaction between epithelial 
basolateral CAR with PMN-expressed JAM-L [44]. Ultimately, the migrating 
neutrophils arrive at the epithelial apical surface where they remain attached 
transiently (Figure 4).  
This attachment enables the PMNs to form a defensive barricade, achieve a 
critical concentration for maximal activity, and eradicate the invading pathogen. In 
order to enable PMN adhesion on the epithelial cell apical surface, PMNs should 
engage in an adhesive interaction with the epithelial cell. The interacting partners 
involved in this important step are now being recognized. For example DAF, a 
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glycosyl-phosphatidylinositol like protein, is important for detaching neutrophils 
from the apical surface. Blocking DAF diminishes the neutrophil transepithelial 
migration and promotes neutrophil accumulation at the apical surface [58]. 
Likewise, a variant of CD44 called CD44v6 was found to mediate detachment of 
neutrophils from the intestinal epithelial apical surface [59]. ICAM-1 has been 
shown to tether neutrophils at the apical-epithelial surface in both airway and 
gastrointestinal epithelial cell lines [10, 51, 52]. There is an apparent balance to 
neutrophil adhesion at the apical surface but how this is regulated and whether 
there are other major players is unknown.  
Numerous human pathologies correlate with the intensity of neutrophil 
migration and the duration of neutrophil retention within the tissue or luminal space 
[1, 60].  In particular, several airway diseases, such as CF and COPD, are 
associated with persistent neutrophils at the epithelial surface [61, 62]. The vast 
majority of studies and therapeutic approaches have targeted neutrophils to 
combat neutrophilia. However, this has a global effect and predisposes for the 
secondary infection. In contrast, tissue-targeted approaches may yield improved 
disease-specific therapeutics with fewer side effects. For example proteins 
expressed on the epithelial cell surface, which are involved in recruiting or retaining 
neutrophils can be targeted in case of airway inflammatory diseases. The fact that 
CAREx8 localizes at the apical surface of the epithelial cells and that  
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Figure 4 Schematic of the major steps of neutrophil transepithelial migration. 1. 
Migrating neutrophils attach to the basal surface of the epithelium via an interaction 
between neutrophil-CD11b/CD18 and epithelial ligand that is yet to be identified. 2. 
Attached neutrophils migrate through the paracellular space between the adjacent 
epithelial cells. Interaction between CAREx7 and JAML at the paracellular space is shown. 
3. Finally, the neutrophils crawl up to the apical surface where they remain attached. I 
hypothesize that CAREx8 mediated interaction is important for adhesion at the apical 
surface. 
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the extracellular domain of CAR can bind to JAML on the neutrophils, suggests 
that CAREx8 might be involved in adhering neutrophils at the apical surface of 
epithelia.  
1.8. Inflammatory diseases:  
Inflammatory diseases are characterized by dysregulated inflammation, 
which results in the uncontrolled recruitment of PMN to the epithelial cell surface. 
Common examples of inflammatory diseases include inflammatory bowel disease, 
which affects the gastrointestinal system, and COPD, asthma, and CF, all of which 
affect airway epithelial tissues. CF is an inflammatory disease that affects around 
30,000 individuals in the U.S. and 70,000 worldwide [63].  The disease ensues as 
a consequence of a mutation in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene. The CFTR gene codes for a cAMP regulated chloride 
channel that is crucial for maintaining homeostasis by controlling the osmotic 
balance and movement of water across the epithelium. As a result of a genetic 
mutation, CFTR malfunctions, which results in the hyperabsorption of water and 
the dehydration of the mucus. The resulting jelly-like mucus is sticky and adheres 
to the epithelial cell surface causing reduced mucociliary clearance, airway 
obstruction, inflammation, and pathogenic invasion [63-65].  
CF lung is characterized by repeated infections (both bacterial and viral), 
increased inflammation and the excessive infiltration of neutrophils. Adenoviral 
infections are common in cystic fibrosis patients [66-68] and rank second in the 
respiratory viruses obtained from young CF patients [66]. Although some of the 
commonly detected viruses found in patients with cystic fibrosis (CF) include 
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rhinovirus, human corona virus and parainfluenza virus, these viruses do not 
contribute to the course of CF disease [67]. However, adenovirus infection is 
associated with deterioration of lung function in CF [68]. The predisposing factors 
that contribute for the high prevalence of viral infections in the patients with 
inflammatory disease is not well understood and is likely complex. The 
accumulation of neutrophils on the epithelial cell surface in inflammatory diseases 
causes considerable damage to the surrounding tissue [69]. All these facts suggest 
the importance of understanding the epithelial cell susceptibility to adenoviral 
infection in the presence of accumulated neutrophils.  
1.9. Cytokines regulate viral infection:  
The expression and localization of both apical and junctional adhesion proteins in 
epithelial cells are regulated by various factors including cytokines [53, 70, 71]. 
Cytokines are released by the epithelial cells themselves and by the resident 
macrophages [70, 71]. For example, TNF-α and IFN- induce ICAM-1 and 
subsequently enhance rhinovirus binding on airway epithelial cells [53]. Lutschg et 
al., 2010, demonstrated that IL-8 increases the airway epithelial cell susceptibility 
to adenoviral infection. They also demonstrated that IL-8 causes the translocation 
of αvβ3 integrin onto the apical surface of airway epithelia [71]. Integrins are 
adenovirus co-receptors that facilitate adenoviral entry into the cell by increased 
endocytosis and endosomal escape [25, 32]. However, CAR is the primary 
receptor that mediates efficient virus attachment, the crucial step that occurs prior 
to viral entry [15, 31, 72]. Even though, the cells that express integrins but not CAR 
are susceptible to adenovirus infection, addition of CAR increases infection by over 
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200-fold [73]. Since CAREx8 naturally localizes at the epithelial apical surface, it is 
likely that CAREx8 is downstream of IL-8 signaling.  Also, very little is known about 
the regulation of CAREx8. Understanding the regulation of CAREx8 is important 
because modulating the concentration CAREx8 at epithelial apical surface is 
predicted to have direct implications in epithelial cell susceptibility to adenoviral 
infection. Therefore, I hypothesized that IL-8 increases the expression and the 
apical localization of CAREx8 in polarized airway epithelial cells.  
 The endogenous biological function of CAREx8 is not known. It is predicted 
that CAREx8 is localized at the apical epithelial cell surface to carry out an important 
biological function for the host cell rather than serving as a viral receptor. As 
mentioned earlier, CAREx7 (basal CAR) has been shown to interact with JAML, on 
the surface of neutrophils. Since the region that binds to JAML is identical between 
the two transmembrane isoforms of CAR, we predict that CAREx8 can tether 
neutrophils to the apical surface. Thus I hypothesized that CAREx8 tethers 
infiltrating neutrophils at the airway epithelial apical surface. 
Epithelial cells serve as a platform for the infiltrating neutrophils to adhere 
during inflammation. This enables the neutrophils to accomplish close encounters 
with pathogens leading to subsequent eradication of the pathogen. However, 
under pathological conditions, such as in inflammatory diseases, the accumulated 
neutrophils cause damage to the epithelial tissue, leading to secondary infections 
including viral infections. Thus I hypothesized that that adhered neutrophils at 
the epithelial surface promotes adenoviral infection.   
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The overarching hypothesis of my thesis was that IL-8 increases the 
expression and the apical localization of CAREx8, that CAREx8 tethers 
infiltrating neutrophils at the apical surface of the airway and that the 
adhered neutrophils augment adenoviral infection.  
This overarching hypothesis was tested by 3 specific aims: 
Specific Aims: 
1) To test if IL-8 increases the expression and the apical localization of CAREx8 
in polarized airway epithelial cells and to determine the mechanism 
underlying this increase.  
2) To test if CAREx8 tethers infiltrating neutrophils at the epithelial apical 
surface 
3) To test if the neutrophils adhered at the epithelial apical surface augment 
adenoviral infection.  
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Chapter 2: Materials and Methods: 
2.1. Reagents 
Antibodies specific for CAR, 1605p (total CAR) and 5678 (CAREx8-specific) have 
previously been described [18, 20, 74]. Recombinant human IL-8 was purchased 
from Gold Biotechnologies, (St. Louis, MO). Anti-GSK3β, phosphospecific GSK3β-
S9, anti-ribosomal subunit S6 kinase (S6K), phosphospecific S6K, anti-AKT, and 
phosphospecific AKT antibodies were purchased from Cell Signaling (Beverly, 
MA); anti-β-actin and anti-E-cadherin antibodies were obtained from Life 
Technologies (Grand Island, NY). CMV-driven Myc-S6K plasmid was a kind gift 
from Dr. Julian-Gomez Cambronero (Wright State University). Horseradish 
peroxidase-labelled secondary antibodies were purchased from Jackson 
ImmunoResearch (West Grove, PA). Adenovirus serotype 5 encoding β-
galactosidase (Ad5-β-Gal) originated from the University of Iowa Gene Transfer 
Vector Core (Iowa City, IA). 
2.2. Cell culture 
The human airway epithelial cell line Calu-3 (ATCC HTB55) was cultured in RPMI 
1640 media containing L-glutamine and 25mM HEPES, supplemented with 10% 
fetal bovine serum and penicillin/streptomycin. Cultured primary human airway 
tracheal epithelial cells were a kind gift from Dr. Joseph Zabner       
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(University of Iowa Cells and Tissue Core) and were isolated from the lungs of 
deceased healthy donors. The primary cells were propagated as described [75]. 
Briefly, human primary airway epithelial cells were co-cultured with irradiated 3T3-
J2 feeder cells [76] in F-media (3:1(v/v) DMEM-F-12, 5% FBS, 0.4 µg/mL 
hydrocortisone, 5 µg/ml Insulin, 8.4 ng/ml cholera toxin, 10 ng/ml epidermal growth 
factor and 5 µM Y-27632 ROCK inhibitor). The cells were maintained at 37°C in a 
humidified incubator with 5% CO2. The epithelial cells were spilt when they 
reached approximately 80-90% confluency; splitting the epithelial cells involved 
the use of differential trypsinization to first detach and remove the 3T3-J2 cells, 
followed by a PBS wash and fresh trypsinization to detach human primary airway 
epithelial cells. The airway cells were then resuspended in fresh F-media for 
passaging or polarization.  
2.3. Cell polarization, TER, and conductance.  
Cell polarization can be achieved in different ways. It is well accepted that cells 
able to polarize will do so once reaching 100% confluence in standard tissue 
culture dishes or on glass coverslips [16, 42, 77, 78]. Epithelial polarization upon 
reaching 100% confluency has been demonstrated by differential localization of 
apical and basolateral proteins, the formation of tight junctions, the restriction in 
viral entry via basolateral receptors, such as CAR, and selective movement of 
small molecules or ions. For polarization on plastic or glass, Calu-3 cells seeded 
at 40% confluence in regular growth media reach 100% confluence over the next 
2-3 days. Experiments were performed at day 3 since cells allowed to continue to 
polarize become multi-layered. Primary human airway cells seeded at 60% 
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confluence were polarized in 1:1 v/v DMEM-F-12 supplemented with 2% ultroser 
G and penicillin/streptomycin, and routinely kept in culture as confluent epithelia 
for over 7-10 days before experiments were performed.  
While polarization under standard conditions has some advantages, such as a 
larger surface area, high optic resolution for microscopy, and lower expense, 
experiments that require access to the basolateral surface or determination of 
transepithelial resistance are not possible. In this case, cells polarized on 
semipermeable membranes, such as millicells (Millipore, Bedford, MA) with 0.4 µm 
pores for standard hyperpolarization experiments or 3 µm pores for transmigration 
studies, were grown at the air-liquid interface. Epithelia grown at the air-liquid 
interface actively pump fluid off of the apical surface resulting in a “dry” 
appearance, with only a few µl of airway surface liquid covering the epithelium. 
This appearance is a surrogate marker for polarization and can be disrupted by 
molecules that break the junctions [42]. The same media as indicated above was 
used to polarize epithelia grown at the air-liquid interface on millicells. Any media 
on the apical surface of the cells was removed every alternate day in order to 
establish and maintain an air-liquid interface. Epithelia were considered polarized 
when the apical surface appeared “dry” and the transepithelial resistance (TER) 
was above 600 Ω/cm2 [18, 79]. TER was measured using a millicell ERS meter 
with a chopstick electrode (Millipore, Bedford, MA), as previously described [42]. 
2.4. AdV-β-Gal infection and β-galactosidase assay.  
Based on the needs of the experiment, either Calu-3 or MDCK cells were infected 
with AdV-β-Gal at a multiplicity of infection (MOI) of 100 plaque forming units (pfu) 
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per cell, or MOI as indicated in the text, for 1 h at 37°C. Virus inoculums were 
removed and cells were washed 2 times with PBS and incubated for additional 24 
H prior to lysis. The protein concentration was determined by a Bio-Rad protein 
assay (Hercules, CA), and β-galactosidase expression was determined with a 
Galacto-Light Plus system (Applied Biosystems, Carlsbad, CA) as previously 
described [18]. 
2.5. Quantitation of viral entry 
Based on the needs of the experiment, either Calu-3 or MDCK cells were polarized 
on a 24-well dish. The polarized cells were then treated as indicated in the text, 
washed three times with 1X PBS, infected with Ad5-βGal at MOI 100 for 1 H, 
washed with PBS, and incubated at 37⁰C for 24 H. To determine viral entry based 
on viral genomes (Vg), total DNA was isolated from the cells using Qiagen DNeasy 
Blood and Tissue kit according to the manufacturer’s protocol and Vg was 
quantitated by quantitative PCR (qPCR) using SYBRG with low ROX (Qunata, 
Gaithersburg, MD) in Stratagene’s Real Time PCR system (Agilent Technologies, 
Santa Clara, CA) with primers for adenovirus-hexon gene, GAPDH, or MDCK 
actin, as previously described [20] and listed in Table 2.  
A control experiment was performed to confirm that Ad5-β-gal Vg reflects actual 
entry of the virus into the epithelial cells rather than just attachment to the epithelial 
cell surface. Epithelial cells that were infected with Ad5-β-Gal, as above for 24 H, 
were treated with (or without) trypsin for 20 min at 37°C to cleave any adherent 
virus on the cell surface [80]. Genomic DNA was isolated and qPCR analysis was 
performed as described above. No difference in Vg was observed between the 
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Ad5-β-Gal infected epithelia with or without trypsin treatment (Figure 5) suggesting 
that viral genomes were protected within the epithelial cells.   
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Table 2: List of primer sequences used for qPCR 
 
 
 
  
Primer Set Forward primer 5’ -> 3’ Reverse Primer 5’ ->  3’ 
Ad Hexon 
specific primer 
ACGCCTCGGAGTACCTG
AG 
GTGGGGTTTCTGAACTTGT 
CAREx8 
TCGGCAGTAATCATTCAT
CCCTGG 
ACTGTAATTCCATCAGTCT
TGTAAGGG 
CAREx7 
TCGGCAGTAATCATTCAT
CCCTGG 
ACTATAGACCCATCCTTGC
TCTGTG 
E-cadherin 
CCCAATAGATCTCCCTTC
ACAG 
CCACCTCTAAGGCCATCTT
TG 
GAPDH 
CACCCTGTTGCTGTAGCC
AAA 
CAACAGCGACACCCACTC
CT 
MDCK actin 
AAGATCTGGCACCACAC
CTTCTAC 
ATCTGGGTCATCTTCTCAC
GGTTG 
CAREx8 (stable 
MDCK-CAREx8) 
GTCCCTCCTTCAAATAAA
GCTG 
ACTGTAATTCCATCAGTCT
TGTAAGGG 
CAREx7 (stable 
MDCK-CAREx7) 
GTCCCTCCTTCAAATAAA
GCTG 
CGGATCCCTATACTATAGA
CCCATC 
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Figure 5: Quantitative PCR measurement of Ad5 viral genomes 24 hours post 
infection represents internalized DNA. MDCK cells were infected with Ad5-β-Gal for 1 
H. Post infection, the epithelial cells were incubated at 37°C for 24 H. Next the cells were 
either treated or untreated with trypsin at 37°C for 20 min to cleave off any virus adherent 
on the cell surface. Cells were washed and genomic DNA was isolated for qPCR analysis. 
No significant difference was observed between the trypsin treated and untreated 
conditions.   
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2.6. Western blot analysis 
Cells were seeded on a 6-well dish and grown to 100% confluency. The cells were 
then treated with the indicated amount of IL-8 for 4 H, unless otherwise stated. 
Post treatment, the cells were washed with ice-cold PBS, and lysed with lysis 
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, protease inhibitors (10 
mg/ml) leupeptin, aprotinin, pepstatin, and 1 mM phenyl-methylsulfonyl fluoride) 
by rocking at 4°C. Cells were scraped, sonicated with five pulses, and centrifuged 
at 14,000 g for 10 min at 4°C in a microcentrifuge. Protein concentration was 
determined with the Bio-Rad protein assay (Bio-Rad, Hercules, CA). Equal 
amounts of protein were subjected to 10% polyacrylamide gel electrophoresis. 
Gels were transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, 
Bedford, MA), blocked with 5% BSA, washed with TBST, and probed with 
appropriate primary antibodies  as described previously [18, 20, 74] and listed in 
Table 3. The secondary HRP conjugated antibodies were used at 1:3000 dilution. 
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Table 3: Primary antibodies and the dilution at which they were used. 
 
Antibody Dilutions used 
Total CAR (1605) 1:1000 
CAREx8 (5678p) 1:200 
E-cadherin 1:4000 
Actin 1:5000 
GSK3β and phospho-GSK3β-S9 1:1000 
AKT and phospho AKT 1:1000 
S6K and phospo-S6K 1:1000 
Myc 1:2000 
FLAG 1:2000 
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2.7. RNA extraction, cDNA synthesis, and quantitative PCR (qPCR) 
After the appropriate treatment of polarized cells with IL-8 for 4 H, total RNA was 
extracted with Trizol reagent, as per the manufacturer’s directions (Life 
Technologies, Grand Island, NY). RNA concentration was estimated at 260/280nm 
and 1 µg was used to generate cDNA (Quanta Bioscience cDNA Synthesis kit). 
The cDNA generated was used for qPCR to specifically quantitate CAREx7, 
CAREx8, E-cadherin, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
RNA levels. Details of the specific primers used to determine the levels of CAREx7, 
CAREx8, and GAPDH have been previously described [20] and listed in table 2. 
qPCR was performed using SYBR Green with low ROX (Quanta, Gaithersburg, 
MD) in Stratagene’s Real Time PCR System (Agilent Technologies, Santa Clara, 
CA). Abundance relative to GAPDH gene expression was calculated for each gene 
of interest and the expression of target genes was quantified via comparative delta 
delta Ct analysis by using Mx4000p software v5 for data analysis.  
2.8. Cell surface biotinylation  
Cell surface biotinylation was performed as previously described [18-20]. Briefly, 
after IL-8 treatment for 4 H, polarized cells were treated with 1 mg/ml Sulfo-NHS-
SS-biotin (Thermo Scientific, Rockford, IL) for 1 H at 4°C with rocking, washed with 
ice cold PBS, and then any remaining free Sulfo-NHS-SS-biotin quenched with ice 
cold 100 mM glycine for 20 min at 4°C. The cells were then washed three times 
with PBS including Ca2+ and Mg2+ (PBS +/+) and lysed with lysis buffer as 
described above. NeutrAvidin beads (Thermo Scientific, Rockford, IL) were added 
to the clarified cell lysate and incubated at 4°C for 2 H with rotation. The 
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NeutrAvidin beads were then collected by centrifugation at 1,000 g at 4°C for 3 min 
and washed three times with ice-cold wash buffer. The sulfo-NHS-SS-biotin-
labeled proteins were eluted from the NeutrAvidin beads with SDS-PAGE sample 
buffer at 65°C for 10 min. This was followed by SDS-PAGE and Western blotting 
using appropriate antibodies. 
2.9. Generation of MDCK stable cells 
To generate MDCK stable cells, the Lenti-X Tet-On advanced inducible expression 
system was used (Clontech. Cat no: 632162) according to the manufacturer’s 
protocol. First, the gene encoding FLAG-tagged human CAREx8 or FLAG-tagged 
human CAREx7 or mCherry (Clontech) was cloned into the pLVX-tight-puro vector 
using the infusion cloning kit (Clontech). pLVX-Tet-on advanced, as well as the 
pLVX-tight-puro plasmid, were then packaged separately into the lentivirus by 
transfecting the plasmids into the 293T packaging cell line along with the Lenti-X 
HTX packaging system using X-fect transfection reagents (Clontech). The Lenti-X 
HTX packaging system contains the plasmid mixture that expresses the necessary 
lentiviral packaging components such as Pol, Tat, Rev, and Gag proteins. The 
lentiviruses produced via this process were called either tet-on, CAREx8, CAREx7, 
or m-Cherry lentivirus. MDCK cells were first infected with the tet-on virus in the 
presence of a neomycin antibiotic drug that selects for tet-on transduced cells. The 
neomycin resistant clones were used for further selection. The selection process 
was carried out in a 96-well dish in order to obtain clones of single cells expressing 
the tet-on gene. The neomycin resistant clones obtained were serially diluted such 
that when seeded on a 96-well plate there was only one cell per well.  The wells 
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that had one positive cell each were selected and allowed to expand and replicate.  
Such clones were further screened for the stable expression of pLVX-tet-on, 
morphology similar to parental cells, and the ability to form an epithelium. This 
newly created MDCK cell line was named MDCK-tet-on cells. Next, the MDCK tet-
on cells were transduced with an additional pLVX-tight-puro lentivirus carrying our 
gene of interest in the presence of puromycin (a drug that selects for the pLVX-
tight-puro transduced cells). The resulting clones were selected and screened, as 
described above, for the stable expression of FLAG-CAREx8, FLAG-CAREx7, or 
mCherry. These new cell lines based on MDCK-tet-on were named MDCK-
CAREx8, MDCK-CAREx7, or MDCK-mCherry. They will also be collectively referred 
to as the MDCK stable cells. The MDCK stable cells were characterized for no 
obvious changes in transepithelial resistance (TER) or changes in the expression 
of the different junctional proteins (e.g. both CAR isoforms, ZO-1, E-cadherin) both 
by Western blot and immunocytochemistry prior to use in later experiments.  
2.10. Isolation of primary neutrophils  
To isolate primary neutrophils, 50 ml of blood was drawn from healthy donors in 
EDTA sprayed 10 ml vacutainers under IRB SC# 4765. The blood was equally 
distributed between two 50 ml conicals each containing 7.5 ml of 6% dextran 
prepared in a saline solution. After securely closing the lid, the tubes were inverted 
twice to allow thorough mixing. The tubes were then allowed to incubate at room 
temperature for 30 min. Next, the top phase was removed and transferred into 
another fresh 50 ml conical and centrifuged at 4000 rpm for 3 min at room 
temperature (the remaining bottom phase was bleached). After centrifugation the 
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pellet was gently resuspended in 1 ml of saline and then diluted with up to 35 ml 
of additional saline. To this, 8 ml of ficoll was added to the bottom of the tube using 
a sterile glass pasteur pipette. The mixture was then centrifuged at 740 x g at 40C 
for 15 min with the breaks turned off. After centrifugation, a white ring was visible 
in the interphase that contained monocytes and lymphocytes. This phase was 
aspirated along will the rest of the supernatant leaving the pellet found at the 
bottom of the centrifuged container (the pellet contains neutrophils). The pellet was 
resuspended in 1 ml of saline and placed on ice. To lyse the contaminating red 
blood cells, 20 ml of ice cold water was added to the resuspended pellet and mixed 
well by pipetting up and down twice. The tube was then placed on ice for no more 
than 40 seconds. Immediately after, 20 ml of ice cold 1.8% NaCl was added, mixed 
gently and centrifuged at 740 x g at 40C for 4 min. The supernatant was discarded 
and the pellet was resuspended in 1ml HBSS-/- (Hanks balanced salt solution 
without calcium and magnesium) followed by the addition of another 9 ml of HBSS-
/-. The neutrophil cell count was determined by using a hemocytometer.  
2.11. Purification of adenovirus fiber knob 
The plasmid encoding the His-tagged Ad5 FK protein was kindly provided by Dr. 
Glen Nemerow (The Scripps Research Institute). The Ad5 FK plasmid was  
transformed into Rosetta (BL21) Escherichia coli cells (EMD Chemicals, 
Gibbstown, NJ), which were grown in LB broth to an optical density of 0.75 at 
600nm (OD600),  induced with 0.3 mM isopropyl-D-1-thiogalactopyranoside 
(IPTG), and subsequently incubated for an additional 4 h at 32°C. The cells were 
then harvested by centrifugation, and the pellets were resuspended in bacterial 
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lysis buffer (5 mM Sodium ohosphate, 100 µM sodium orthovanidate, 300 µg/ml 
lysozyme, 10 mM imidazole, 1% triton-X 100, 20% glycerol and 2X protease 
inhibitor cocktail (Sigma-Aldrich)). The resuspended cells were sonicated on ice 
for 6 min with 30 s pulses and centrifuged at 14,000 X g at 4°C for 20 min. 2 ml of 
HisPur Ni-NTA superflow agarose (Thermo Scientific) was added and incubated 
at 4°C with rotation for 1.5 H to allow the His-tagged protein to bind to the resin. 
Next, the resin was centrifuged to remove the supernatant and the resin was 
washed thrice with the wash buffer (50 mM sodium phosphate pH 7.0, 10 mM 
imidazole). After washing, the resin was resuspended in the elution buffer (50 mM 
sodium phosphate, 500 mM NaCl and 300 mM imidazole), incubated for 5 min at 
4°C, and centrifuged.  After centrifugation, the supernatant was saved. This step 
was repeated 3-5 times. The elutes were pooled, concentrated, and dialyzed into 
a buffer containing 20 mM Tris and 100 mM NaCl. The protein concentration was 
measured using Bradford’s (BioRad) method according to the manufacturer’s 
protocol. Routinely ~10 g/ml concentration of the purified protein was obtained. 
2.12. Neutrophil adhesion assay 
MDCK-CAREx8, MDCK-CAREx7 and MDCK-mCherry cells were seeded on a 24-
well dish at 1X105 cells per well, a concentration that allows these cell lines to reach 
100% confluence by day 3. Once at 100% confluence and polarized, the cells were 
induced with increasing concentration of DOX (0 to 1000 ng/ml) for 24 H to allow 
the overexpression of FLAG-CAREx8, FLAG-CAREx7, or mCherry respectively. The 
following day, neutrophils were isolated from the peripheral blood of healthy donors 
and resuspended in HBSS-/-. The neutrophils were then stained with 1.5 µM 
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calcein green for 30 min at 37°C. The stained neutrophils were washed once with 
HBSS-/- and resuspended in HBSS+/+ (HBSS with calcium and magnesium). The 
required number of stained neutrophils were then added to the MDCK apical cell 
surface.  To block neutrophil adhesion, the epithelial cells were incubated with 
either purified Ad5 FK or purified control Ad type 3 FK (a group B adenovirus FK 
that does not bind CAR) for 10 min at room temperature prior to the addition of the 
neutrophils. After the addition of the neutrophils, the culture plates were spun down 
at 140 x g for 4 min with the breaks of the centrifuge turned off. The epithelial cells 
were then incubated for 15 min at 37°C to allow for neutrophil adhesion. Next, the 
epithelial cells were washed 3 times with HBSS+/+ to remove the unbound 
neutrophils. The bound neutrophils were imaged using fluorescence microscopy 
and the fluorescence intensity was quantitated using Metamorph software. 
Additionally, Calu-3 cells were seeded on the 24 well dish at 2 X 105 cells/well and 
allowed to reach confluency on the dish. On the day of the adhesion assay, these 
Calu-3 cells were treated with IL-8 (30 ng/ml) for 4 H. Post treatment, a neutrophil 
adhesion assay was performed as described above. 
2.13. Polarization of MDCK stable cells for transmigration assay 
To perform the neutrophil transmigration assay, the MDCK-stable cells were 
polarized on millicells in an inverted fashion. Millicells of 3µM pore size were 
purchased from Millipore (Cat no: PITP01250). First the Millicells were placed in a 
12-well dish in an upright fashion. 4.5 ml of media was added to the well (at this 
point the millicell will be fully submerged). Then, the millicells were inverted 
(membrane facing up) using a sterile glass pipette.  It was then necessary to make 
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sure that no air bubbles were trapped inside the millicell. Next, 1.7 ml of the media 
was removed from the 12-well dish (leaving the membrane of the millicell exposed 
to air). Slowly, the millicell was moved to the center of the well using the glass 
pipette. Now 1 X 105 of MDCK stable cells, resuspended in 80 ul of the media were 
added to the membrane. This set up was then incubated at 37°C for 72 H. Next, 
the TER of the cells was measured. To measure the TER, the millicells were 
transferred to a 24-well dish containing 600µl of HBSS+/+. 400µl of the HBSS+/+ 
was then added to the inside of the millicell (the equivalent of the basal surface). 
The cells were allowed to equilibrate by incubating at 37°C for 30 min. The TER 
was then measured and epithelia were considered polarized if the TER was at 
least 600 Ω/cm2.  After attaining appropriate TER, the millicells were transferred to 
24-well dish containing media with or without DOX (200 ng/ml) for additional 24 H 
in the upright direction. The media was added both on the apical and the 
basolateral surfaces. Next day, the neutrophil transmigration assay was 
performed. 
2.14. Neutrophil transmigration assay  
The setup used for the transmigration assay is shown in the model in (Figure 27). 
Briefly, to perform the neutrophil transmigration assay, the MDCK-stable cells that 
were polarized on millicells (3 µM pore) in an inverted fashion were used. Before 
performing the neutrophil transmigration assay, the MDCK-stable cells were 
washed once with HBSS+/+, allowed to equilibrate at 37°C for 30 min and were 
measured with a chopstick ohmmeter to determine the TER. The millicells were 
then transferred to a fresh 24-well dish that contained 500 µl of 100 nM fMLP 
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(formyl-methionyl-leucyl-phenylalanine, a neutrophil chemoattractant) in HBSS+/+ 
(i.e the fMLP containing HBSS+/+ is on the apical surface of the epithelial cells). 1 
X 106 neutrophils, fluorescently stained with calcein green and resuspended in 
HBSS+/+, were added to the basal surface of the epithelial cells (i.e. inside of the 
millicell cup) and allowed to transmigrate through the epithelium towards the apical 
surface for 60 min at 37°C. Post neutrophil transmigration, the neutrophils that 
successfully transmigrated to the bottom chamber were imaged under a 
fluorescent microscope and quantitated using MetaMorph software. 
2.15. Identifying neutrophils adhered to the epithelial apical surface 
After performing the neutrophil transmigration assay, the neutrophils that remained 
adhered to the epithelial apical surface were detached using the following protocol: 
First the millicells were transferred to a fresh 24-well dish that contained 500µl of 
HBSS+/+. The basal surface of the millicells were washed 3 times with HBSS+/+ 
in order to remove any neutrophils that failed to migrate into or through the 
epithelium. Next, the millicells were centrifuged at 50 X g for 5 min. The millicells 
were discarded and the neutrophils that detached from the epithelial apical surface 
were imaged under a fluorescent microscope and quantitated using MetaMorph 
software. 
2.16. Adenoviral transduction in the presence of neutrophils 
MDCK-CAREx8, MDCK-CAREx7 and MDCK-mCherry cells were either induced or 
mock-induced with DOX or diluent, respectively. A neutrophil adhesion assay was 
then performed as described earlier. Subsequently, the unbound neutrophils were 
washed off and the epithelial cells were infected with the indicated MOI of Ad5-β-
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Gal for 1 H. After 24 H of incubation the DNA was extracted and the viral genomes 
were quantitated to determine the fold change in viral entry. 
2.17. Statistical analysis  
All experiments were performed at least three times. Microsoft Excel and Graph 
Pad Prism V5 (La Jolla, CA) were used to perform statistical analyses. Significant 
differences were analyzed using one-way or two-way ANOVA tests, followed by T-
test to determine individual differences between control and experimental 
conditions. Results were considered to be statistically significant if a p<0.05 was 
obtained. 
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Chapter 3: IL-8 regulates the protein expression and the localization of 
CAREx8 via differential activation of AKT/S6K and inactivation of GSK3β 
Epithelial cells pose a formidable barrier to the invading pathogens including 
adenoviruses. Viruses have evolved to break the barrier using mechanisms that 
are just starting to be understood. Some viruses use the junctional proteins that 
are sequestered beneath the epithelial tight junctions, other utilize the apical 
proteins. Adenoviruses use CAR for entry into polarized epithelial cells. The 
alternatively spliced isoform, CAREx8, is able to localize at the apical surface. Thus 
adenovirus is provided with an opportunity to bind and enter the epithelial cells 
from the apical surface. Therefore, any changes in the levels of CAREx8 expression 
will have a direct implication for the susceptibility of a polarized epithelium to 
adenoviral infection. The expression and the localization of several epithelial 
junctional and apical proteins are regulated by proinflammatory cytokines. IL-8 has 
been shown to increase the apical localization of αvβ3 integrin and increase the 
susceptibility of a polarized epithelium to adenovirus infection. Therefore, I 
hypothesized that IL-8 increases the apical localization and expression of CAREx8 
in airway epithelial cells. This hypothesis was tested through three specific aims:  
3.1. To test if IL-8 increases CAREx8 expression and apical localization in the 
human airway epithelial Calu-3 cell line  
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3.2. To validate that IL-8 increases CAREx8 expression and apical localization 
in primary human airway epithelial cells.  
3.3. To determine the molecular mechanism underlying the IL-8 mediated 
increase in CAREx8 expression. 
 
3.1. IL-8 increases CAREx8 expression and apical localization in the human 
airway epithelial Calu-3 cell line. 
3.1.1. Rationale:  
Proinflammatory cytokines are released by the resident macrophages during viral 
infection in the lung. Previous studies have shown that IL-8, a proinflammatory 
cytokine and neutrophil chemoattractant, increases the airway susceptibility to 
adenoviral infection [71]. However, the mechanism underlying this increase in 
susceptibility remains unclear. IL-8 has been shown to relocalize integrins to the 
epithelial apical surface. Integrins are adenoviral co-receptors that aid in the steps 
of viral entry that occur after viral attachment to the host cell. Viral attachment on 
the epithelial cell surface is accomplished when the virus binds to its primary 
receptor. For most adenoviruses, CAR is the primary receptor. Lutschg et al., 2010 
[71] demonstrated that IL-8 increases the airway epithelial cell susceptibility to 
adenoviral infection. The focus of their study was integrins which are co-receptors 
for adenoviral entry. However, CAR is the primary receptor for adenoviral infection 
and they provided limited evidence that CAR localizes at the apical surface post 
IL-8 treatment. Moreover, this study did not differentiate between the two isoforms 
of CAR, CAREx7 (the basolateral isoform) and CAREx8 (the apical isoform). 
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Therefore, we hypothesized that IL-8 upregulates CAREx8 expression and apical 
localization in airway epithelial cells. To test this hypothesis we used Calu-3 cells  
an accepted model system for studies of human airway epithelia [81]. Although 
Calu-3 cells are derived from human lung adenocarcinoma [82], Calu-3 cells  are 
able to differentiate and polarize into an electrically tight epithelium that resembles 
the broncho-alveolar epithelium [81].  
3.1.2. Results:   
IL-8 increases airway epithelial cell susceptibility to adenoviral infection and 
CAREx8 protein expression.  
We first tested the effect of IL-8 on the susceptibility of Calu-3 airway epithelial 
cells to adenoviral infection.  Polarized Calu-3 epithelia were treated with 
increasing concentrations of IL-8 (ranging from 0 ng/ml to 100 ng /ml (0 – 12.5 
nM)) for 4 H, followed by apical infection with Ad5-βGal. Consistent with Lutschg 
et al., 2010, [71] quantitative PCR analysis showed that adenovirus entry was 
increased in response to IL-8 treatment in a dose-dependent manner (Figure 6). 
Viral entry reached its maximum at 3, 10 and 30 ng/ml of IL-8 with ~5-fold increase 
in viral genomes (Vg) when compared to 0 ng/ml IL-8. At 100 ng/ml, viral entry was 
decreased when compared to 30 ng/ml IL-8. Explanations for this could be that 
signaling is saturated or the cell is no longer able to respond to the higher 
concentration of IL-8 as a result of desensitization of the receptors,  receptor 
internalization, or receptor degradation.  
I then asked how IL-8 promotes adenoviral infection in these polarized cells. Since 
the primary receptor for Ad5 is CAR, we tested the expression of CAR in the 
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presence of IL-8. In particular, we examined the expression of the apical isoform 
of CAR, CAREx8. IL-8 treatment stimulated CAREx8 expression in a dose-
dependent manner with the maximal effect at a concentration of 30 ng/ml (Figure 
7). More intriguingly, the IL-8-mediated effect appeared to be CAREx8-specific. 
Analysis of total CAR, which is predominantly composed of the CAREx7 isoform [18, 
19], and E-cadherin (another junctional protein) did not show a significant change 
in protein expression (Figure 7). IL-8 had the maximal effect on CAREx8 expression 
between 4-12 H of treatment (Figure 8). Based on these data, further experiments 
were carried out with 30 ng/ml IL-8 for 4 H, at time point where the change in 
CAREx8 protein expression was obvious and amenable to experimental analysis.  
IL-8 stimulates apical CAREx8 protein localization.  
In order to determine whether IL-8 enhances the apical localization of CAREx8, we 
performed apical-surface biotinylation of polarized Calu-3 epithelia. IL-8 
significantly increased the apical localization of CAREx8 in polarized Calu-3 cells in 
a dose-dependent manner (Figure 9). In addition, actin, a negative control, was 
not detected with apical proteins. Together, the above data indicates that IL-8 
stimulates CAREx8 protein expression at the apical surface of airway epithelial cells 
and that the effect is dose-dependent.  
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Figure 6: IL-8 increases the susceptibility of polarized airway epithelia to 
adenovirus entry. The apical surface of polarized Calu-3 cells was treated with increasing 
concentrations of IL-8 for 4 H and then transduced with Ad5-β-Gal. Total genomic DNA 
was analyzed for the fold change in viral genomes (Vg) relative to GAPDH by qPCR. 
Statistical significance was evaluated using one-way ANOVA and Tukeys post hoc test, * 
P<.05.  
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Figure 7: IL-8 stimulates CAREx8 expression. A) Polarized Calu-3 epithelia were treated 
with increasing concentration of IL-8 for 4 H. Whole cell extracts were then analyzed by 
Western blot for the expression of CAREx8, total CAR, E-cadherin, and actin. B) Band 
intensity of CAREx8 relative to mock treated (0 ng/ml IL-8) (Average of 3 individual 
experiments). The reported values are mean and standard error of the mean (SEM), 
calculated from at least three independent experiments. Statistical significance was 
evaluated using one-way ANOVA and Bonferroni post hoc test. ** P<.01, ***P<0.001. 
  
 
A
100
48
kDa
48
48
IL-8 (ng/ml) 0 1 3 10 30 100
Total CAR
CAREx8
E-cadherin
Actin
0
0.5
1.0
1.5
2.0
IL-8 (ng/ml) 0 1 3 10 30 100
C
A
R
E
x
8
b
a
n
d
 i
n
te
n
s
it
y
 
re
la
ti
v
e
 t
o
 m
o
c
k
 (
0
) 
B
** ***
48 
 
 
 
 
 
 
Figure 8: IL-8 has its maximal effect of CAREx8 expression between 4 and 12 H.  
Polarized Calu-3 epithelia were treated with 30 ng/ml IL-8 for varying lengths of time (0 
to 24 H). Post treatment, CAREx8 protein expression was analyzed by Western blot 
analysis   
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Figure 9: IL-8 stimulates enhanced localization of CAREx8 at the apical surface of 
polarized epithelia. Polarized Calu-3 cells were treated with increasing concentrations 
IL-8 for 4 H prior to apical surface biotinylation. Biotin-labeled proteins were pulled down 
using neutravidin beads and analyzed for the expression of CAREx8 by Western blot. As a 
control, the cytosolic protein actin was probed for in the total lysate (present) and after the 
apical-biotin/neutravidin pull down (absent). 
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3.2. IL-8 increases CAREx8 expression and apical localization in primary 
human airway epithelial cells.  
3.2.1. Rationale:  
Although the Calu-3 cell line is an excellent model of an airway epithelium, this cell 
line is derived from human lung adenocarcinoma and immortalized [81, 82]. 
Therefore it is important to validate the IL-8-mediated effect on CAREx8 expression 
and localization in primary airway epithelial cells. In order to facilitate these studies, 
a new technique that allows the expansion of primary airway cells and subsequent 
differentiation into well-differentiated primary airway epithelia was used [75].  I 
hypothesized that IL-8 will augment the expression and the apical 
localization of CAREx8 in polarized primary airway epithelial cells obtained 
from the trachea of the healthy donors.  
3.2.2. Results: 
Primary human airway epithelial cells can be cultured indefinitely in the 
presence of 3T3-J2 feeder cells and ROCK inhibitor.  Primary airway epithelial 
cells from three different donors were successfully cultured in the presence of 
irradiated 3T3-J2 feeder cells and ROCK inhibitor, as described [75] (Figure 10). 
Upon removal of the feeder cells and the ROCK inhibitor the epithelial cells 
differentiated and polarized. Of the three donors tested, the cells from donor 2 were 
chosen because of their ability to form a highly polarized electrically-tight 
epithelium (TER reached nearly 2000 Ω/cm2). Moreover, the immunofluorescence 
staining revealed the expected localization of junctional proteins.  
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IL-8 augments CAREx8 protein expression and apical localization in primary 
human airway epithelial cells. To validate that IL-8 stimulates CAREx8 protein 
expression and apical localization as was observed with Calu-3 cells, the 
experiments in primary airway epithelial cells were repeated. Similar to Calu-3 
epithelia, apical treatment with 30 ng/ml IL-8 for 4 H resulted in a robust increase 
in CAREx8 protein expression (Figure 11A and B) and apical localization (Figure 
11C). As negative controls for apical surface biotinylation, intracellular actin and 
basolateral E-cadherin were investigated by Western blot. As expected, both were 
present in total lysate but absent from the apical surface. The epithelial barrier 
integrity in the presence of IL-8 was also tested. We observed that IL-8 treatment 
did not alter the TER of the polarized primary airway epithelial cells (Figure 12). 
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Figure 10: Primary airway epithelial cells co-cultured with the irradiated 3T3-J2 
cells. The bright field image shows the primary airway epithelial cells (arrow) growing in 
the presence of irradiated 3T3-J2 cells (arrowhead).  
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Figure 11: IL-8 stimulates CAREx8 expression and apical localization in polarized 
primary airway epithelial cells A) Whole cell extracts of polarized primary human airway 
epithelial cells mock treated (0 ng/ml IL-8) or treated with 30 ng/ml IL-8 were analyzed for 
the expression of CAREx8, E-cadherin, and actin. B) Band intensity of CAREx8 (30 ng/ml IL-
8) relative to mock treated (0 ng/ml IL-8) (Average of 3 individual experiments). C) 
Polarized primary airway epithelial cells were either mock (0 ng/ml IL-8) treated or treated 
with IL-8 at 30 ng/ml for 4 H. Post-treatment apical surface biotinylation was performed. 
Biotin-labeled proteins were pulled down using neutravidin beads and analyzed for the 
apical expression of CAREx8 and the negative control proteins actin and E-cadherin. The 
values reported are the mean and the standard error of the mean (SEM) of 3 individual 
experiments. Statistical significance was evaluated using student t-test, * P<.05.  
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Figure 12: IL-8 treatment does not affect the transepithelial resistance of polarized 
airway epithelia. Polarized primary airway epithelial cells were either mock treated (0 
ng/ml) or treated with IL-8 (30 ng/ml). TER measurements were taken pre- or post-
treatment. 
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3.3. The molecular mechanism underlying the IL-8 mediated increase in 
CAREx8 expression. 
3.3.1. Rationale:  
Protein expression can be regulated in multiple different ways. Two major 
mechanisms involve regulation at the transcriptional level (e.g. mRNA copy 
number) or at the translational level (e.g. the efficiency of converting mRNA to 
protein). I asked whether IL-8 regulates CAREx8 protein expression by one of these 
two mechanisms. Previous studies have shown that in response to IL-8, AKT is 
activated and causes activation of ribosomal S6 kinase (S6K). S6K in turn 
regulates protein synthesis by phosphorylating and activating ribosomal S6 
protein, a key component of active ribosomes [83]. Moreover, our lab has 
demonstrated that GSK3β negatively regulates CAREx8 expression [20]. GSK3β is 
a ubiquitously expressed serine/threonine kinase which plays a crucial role in 
various cellular processes including glucose metabolism, protein synthesis, cell 
motility, and proliferation. GSK3β negatively regulates transcription factors 
including TCF and LEF. Inhibition of GSK3β via phosphorylation at serine 9 
renders GSK3β inactive, which allows transcription factors to enter the cell nucleus 
and activate target-gene transcription [84]. GSK3β has also been shown to 
negatively regulate protein translation by inhibiting eukaryotic initiation factor 2B 
(eIF2B) by inducing phosphorylation at Ser 340. eIF2B is a guanine nucleotide 
exchange factor (GEF) for the small GTPase eIF2. When GSK3β is inhibited, 
eIF2B is activated as a result of dephosphorylation at Ser 340. Activated eIF2B 
further activates eIF2 (GTP coupled) by recruiting the initiator methonyl tRNA to 
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the mRNA and beginning translation [85-89]. I hypothesized that, in addition to 
activating AKT, IL-8 inactivates GSK3β to augment CAREx8 expression.  
3.3.2. Results: 
IL-8 regulation of CAREx8 expression is post transcriptional 
To understand the molecular mechanism underlying the IL-8 mediated increase in 
CAREx8 expression, I sought to first examine whether IL-8 stimulates CAREx8 
expression at the transcriptional and/or at the post transcriptional level. I first tested 
the hypothesis that the CAREx8 increase was via increased transcription. CAREx8-
specific mRNA levels were examined in IL-8 treated or untreated polarized primary 
airway epithelia. IL-8 treatment did not alter the mRNA levels of CAREx8, even at time 
points earlier than 4 H when a transcriptional increase would be expected in order to 
facilitate the protein increase observed by 4 H (Figure 13A). As expected, the mRNA levels 
of CAREx7 and E-cadherin also showed no significant change upon IL-8 treatment (Figure 
13A). In addition, CAREx8 mRNA levels did not change in IL-8-exposed Calu-3 epithelia 
(Figure 13B). These data suggest that IL-8 might stimulate CAREx8 protein synthesis 
without altering its mRNA levels. To further confirm this, the protein synthesis inhibitor, 
cycloheximide (CHX) was used. Remarkably, CHX abolished the IL-8-mediated increase 
in CAREx8 expression both in polarized Calu-3 (Figure 14A) and polarized primary airway 
epithelial cells (Figure 14B). Taken together, these data show that IL-8 stimulates de novo 
CAREx8 protein synthesis that does not require an increase in CAREx8 mRNA levels.  
IL-8 activates AKT and S6K to increase CAREx8 protein expression. 
Next, the roles of the previously mentioned signaling proteins were investigated in 
IL-8-mediated increased CAREx8 expression. Previous studies have shown that 
activation of AKT leads to the downstream activation of ribosomal S6 protein 
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kinase (S6K) [83]. In agreement, we observed a robust activation of AKT (pAKT-
T308) upon IL-8 treatment (Figure 15A). Moreover, inhibition of AKT using 
chemical inhibitor Ly294002 (30 µM) blocked the IL-8-mediated increase in CAREx8 
expression (Figure 15B) and attenuated adenovirus infection (Figure 15C). 
Likewise, we also observed that IL-8 stimulation caused an increase in the 
activated form of S6K, phospho-S6K T389 (Figure 16A). Inhibition of S6K using 
chemical inhibitor RO318220 (300 nM) blocked the IL-8 mediated increase in 
CAREx8 (Figure 16B) and completely blocked the increase in adenovirus infection 
(Figure 16C). Taken together these data show that upon stimulation of airway 
epithelial cells with IL-8, AKT and S6K are activated and both these signaling 
proteins regulate the expression of CAREx8 (Figure 21).  
Given the large effect of the S6K inhibitor on adenovirus infection and to further 
validate these results, we tested whether overexpression of S6K in Calu-3 (Figure 
17A) or COS7 cells (Figure 17B) had an effect on CAREx8 protein expression. 
Overexpression of S6K resulted in a robust increase in the CAREx8 expression both 
in Calu-3 cells and COS7 cells. These data indicate that both AKT and S6K play 
an important role in stimulating CAREx8 expression in response to IL-8 treatment. 
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Figure 13: IL-8 does not alter CAREx8 mRNA levels. A) Polarized primary airway 
epithelia cells were treated with IL-8 for varying lengths of time before RNA extraction and 
qPCR analysis were performed to quantitate the fold change in the gene expression of 
CAREx8, CAREx7 and E-cadherin relative to 0 H control. An average of 3 experiments is 
shown. B) Polarized Calu-3 cells were treated with increasing concentration of IL-8 for 4 
H before RNA extraction and qPCR analysis were performed to quantitate the fold change 
in the gene expression of CAREx8 and CAREx7 relative to untreated (0 ng/ml IL-8) control. 
The values reported are the mean and the standard error of the mean (S.E.M.) of 3 
individual experiments. No significant difference was detected by ANOVA. 
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Figure 14: IL-8 increases new CAREx8 protein synthesis. A) Polarized Calu-3 cells, or 
B) polarized primary airway epithelial cells were either untreated or treated with IL-8 
30ng/ml for 4 H in the absence or presence of cycloheximide (CHX). CAREx8 expression 
in cell lysates was analyzed by Western blot.  
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Figure 15: IL-8 stimulates activation of AKT and augments CAREx8 expression and 
adenoviral infection. A) Polarized Calu-3 epithelia were either untreated or treated with 
30 ng/ml IL-8 for 4 H. pAKT T308 is the activated form of AKT. B) Polarized Calu-3 
epithelia were either untreated or treated with IL-8 in the presence or absence of the AKT 
inhibitor Ly294002 (30 µM) for 4 H Quantitation of relative CAREx8 band intensity 
normalized to actin is shown below the blot. C) Polarized Calu-3 epithelia were either 
untreated or treated with IL-8 30 ng/ml in the presence or absence of AKT inhibitor 
Ly294002 (30 µM) for 4 H followed by infection with Ad5-βGal. Genomic DNA was isolated 
24 H post infection to determine the fold change in viral genomes (vg; viral entry) using 
qPCR. Statistical significance was evaluated using one-way ANOVA and Bonferroni post 
hoc test, ***P<.001.  
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Figure 16: IL-8 stimulates the activation of ribosomal S6 kinase (S6K) and augments 
CAREx8 expression and adenovirus infection. A) Polarized Calu-3 cells were either 
untreated or treated with IL-8 30 ng/ml for 4 H. Whole cell extracts were analyzed by 
Western blot for the expression of total S6K and pS6K T389, the activated form of S6K. 
B) Polarized Calu-3 cells were either untreated or treated with IL-8 30 ng/ml in the 
presence or absence of S6K inhibitor RO318220 (300 nM) for 4 H, Post treatment the 
whole cells extracts were analyzed by WB for CAREx8 expression or C) infected with Ad5-
βGal, followed by genomic DNA extraction and quantitation of the fold change in viral 
genomes (vg; viral entry) using qPCR. Statistical significance was evaluated using one-
way ANOVA and Bonferroni post hoc test, ***P<.001.  
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Figure 17: S6K augments CAREx8 protein expression. A) Polarized Calu-3 cells were 
either untreated or treated with IL-8 30 ng/ml and compared to polarized Calu-3 cells that 
were transfected with a Myc-tagged S6K plasmid. B) COS7 cells were either untransfected 
or transfected with Myc tagged S6K plasmid. Whole cell extracts were prepared form both 
Calu3 and COS7 cells and analyzed by Western blot for expression of myc-tagged S6K, 
CAREx8, and actin. 
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IL-8 signaling inactivates GSK3β which negatively regulates CAREx8 
expression.  
Our lab has previously shown that GSK3β negatively regulates CAREx8 expression 
[20]. Therefore, to further decipher the signaling downstream of IL-8-stimulation, 
the activity of GSK3β was investigated. IL-8 treatment of either Calu-3 cells (Figure 
18A) or primary airway epithelial cells (Figure 18B) resulted in an increase in the 
phosphorylated form of GSK3β at serine 9 (GSK3β-S9). Phosphorylation at S9 
inactivates GSK3β [90, 91]. To further validate the involvement of GSK3β, primary 
airway epithelial cells were treated for 4 H with SB415286 or LiCl which are known 
GSK3β inhibitors [92]. We observed that both GSK3β inhibitors increased CAREx8 
expression to a level similar to that observed with IL-8 treatment (Figure 19A) and 
increased airway epithelial cells susceptibility to adenoviral infection (Figure 19B). 
To our knowledge, this is the first time that IL-8 signaling has been shown to inhibit 
GSK3β. Taken together these data indicate that IL-8 regulates CAREx8 protein 
expression by inhibiting GSK3β.  
AKT/S6K and GSK3β increase CAREx8 through parallel pathways  
 The data above shows that inhibition of GSK3β and over expression of S6K 
each increase apical CAREx8 to a similar degree. To determine whether GSK3β- 
and S6K-mediated regulation of CAREx8 are within the same pathway, polarized 
Calu-3 cells were either untreated or treated with IL-8 30 ng/ml for 4 H in the 
presence GSK3β inhibitor (SB415286, 45 µM) or S6K inhibitor (RO318220, 300 
nM) or in a combination of both SB415286 and RO318220. I predicted that if S6K 
was a downstream target of GSK3β, inhibition of S6K would prohibit increased 
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CAREx8 protein levels when GSK3β was inhibited. However, a standard increase 
in CAREx8 protein levels (Figure 20) was observed indicating that the GSK3β and 
S6K pathways do not overlap.  
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Figure 18: IL-8 treatment results in the inactivation of GSK3β. A) Polarized Calu-3 
cells and B) polarized primary airway epithelial cells were treated with IL-8 30 ng/ml for 4 
H. The expression of GSK3β-S9 (inhibited form of GSK3β) was analyzed by Western blot. 
Protein expression of whole GSK3β and actin were also determined as controls. 
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Figure 19: GSK3β negatively regulates CAREx8 expression and adenoviral infection. 
A) Primary airway epithelial cells were treated with GSK3β inhibitors and CAREx8 
expression was analyzed by Western blot. B) Calu-3 cells were either untreated, treated 
with IL-8 30 ng/ml, or treated with the GSK3β inhibitor SB 415286 for 4 H, followed by 
infection with Ad5-β-Gal. The cells were analyzed 24 H post infection. Experiments were 
repeated at least 3 times; representative Western blot experiments are shown and 
quantified. Statistical significance was evaluated using one-way ANOVA and Bonferroni 
post hoc test, ***P<.001.  
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Figure 20: AKT/S6K and GSK3β increase CAREx8 through parallel pathways. 
Polarized Calu-3 cells were either untreated or treated with IL-8 30 ng/ml for 4 H in the 
presence GSK3β inhibitor (SB415286, 45 µM) or S6K inhibitor (RO318220, 300 nM) or in 
a combination of both SB415286 and RO318220. Whole cell lysates were analyzed by 
Western blot analysis for expression of CAREx8 and actin.  
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Figure 21: Schematic model of the pathway by which IL-8 stimulates an increase in 
CAREx8 protein expression summarizing results. 1) IL-8 binds to the IL-8 receptor 
(CXCR1/2). 2) AKT is activated and GSK3β is inhibited downstream of AKT. 3) Activation 
of AKT in turn activates S6K to increase CAREx8 protein expression. Inhibition of GSK3β 
relieves its inhibition of CAREx8 protein synthesis.  4) Both of these pathways stimulate 
CAREx8 protein synthesis, 5) which increases CAREx8 localization at the apical surface of 
the epithelial cell, and 6) augments adenoviral infection.  
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3.4. Discussion 
We show for the first time that IL-8 stimulates the expression of CAREx8 at the 
apical surface of the polarized airway epithelial cells without altering the mRNA 
levels for CAREx8 (Figures 7, 9, 11, 13 and 14). Consequently, this increases the 
susceptibility of the apical surface of the epithelium to adenovirus infection. We 
demonstrate a novel signaling cascade downstream of IL-8, wherein exposure of 
airway epithelial cells to IL-8 results in the inhibition of GSK3β (Figure 18). 
Additionally, we also observed that IL-8 treatment caused robust activation of AKT 
and S6K, which enhance CAREx8 protein levels leading to increased adenovirus 
infection (Figures 15, 16 and 17). The same mechanism is found in both Calu-3 
cells and well-differentiated primary airway epithelial cells. Primary airway epithelia 
are powerful models since they closely reflect an in vivo airway epithelium [93, 94]. 
These data elucidate a novel signaling mechanism underpinning the regulation of 
the “apical” adenovirus receptor, CAREx8, and bridge a gap in our knowledge of 
how host cytokines enhance viral entry from apical epithelial surfaces.  
Pathogens have developed multiple ways to break into host cells. Many 
pathogens like E. coli and H. pylori breach the epithelial barrier integrity before it 
can infect the cells [95]. Viruses, on the other hand, are sophisticated in that they 
often infect epithelial cells without causing much damage to the barrier integrity 
[16, 17]. For example, Coxsackie B virus binds to DAF which causes translocation 
of the virus to the tight junction where it can interact with CAR and gain entry into 
the cells [16]. Reovirus binds sialic acid at the apical surface which then, mediates 
binding of the virus to its receptor JAM-A in order to enter into the cells [17]. Many 
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inflammatory factors have been shown to modulate viral infections. For example, 
IL-26 increases adsorption of vesicular stomatitis virus onto target cells [96]. In 
fact, viral infections are quite common in inflammatory respiratory diseases such 
as COPD [97], cystic fibrosis [66, 98], and asthma [99]. Our work improves the 
understanding of the mechanisms behind the effect of cytokines on viral infection.  
The proinflammatory cytokine IL-8 belongs to CXCL family of cytokines and 
is one of the first cytokines released by a variety of host cells during a pathogenic 
insult. IL-8 is a neutrophil chemoattractant and modulates numerous cellular 
signaling proteins in a variety of cell types, including epithelial cells [100]. 
Cytokines regulate the expression of various cell surface proteins. For example, 
ICAM-1 is shown to localize at the intestinal epithelial apical surface in response 
to IFN [10]. IFN- also disrupts the epithelial barrier integrity by promoting 
macropinocytosis of tight junction proteins including occludin, claudin-1, and JAM-
A [8, 9]. Exposure of airway epithelial cells to TNF-α in combination with IFN- 
downregulates the expression and delocalizes tight junction proteins JAM and ZO-
1 in airway epithelia, and CAR in endothelial cells [6, 7]. For the first time, we show 
that the stimulation of polarized Calu-3 and primary airway cells with IL-8 augments 
the protein, but not the mRNA levels of CAREx8. Interestingly, the IL-8-mediated 
effect did not affect the expression of CAREx7 or E-cadherin, indicating that the 
regulation may be specific to CAREx8. IL-8 also has an acute effect that stimulates 
maximal CAREx8 expression between 4-12 H. There might be several reasons for 
the acute effect of IL-8 on CAREx8 expression. For example, CAREx8 might be 
crucial in mediating early innate immunological responses. Prolonged signaling 
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may lead to adverse immunological complications due to prolonged inflammation. 
It is also possible that IL-8-mediated signaling undergoes negative feedback to 
inhibit IL-8 signaling by downregulating the IL-8 receptor [101]. Future work will 
focus on these possibilities and the speculation that adenovirus entering into the 
lung on air-suspended droplets may take advantage of the temporary increase in 
apical CAREx8 to invade the epithelium. It is also demonstrated that IL-8 increases 
the CAREx8 protein expression without affecting its mRNA transcript levels. 
Moreover, blocking protein synthesis with CHX, blocked the IL-8-mediated effect 
suggesting that IL-8 signals protein synthesis of CAREx8. In the future, pulse-chase 
experiments using radiolabeled methionine will be more conclusive to prove the 
direct effect of IL-8 on CAREx8 protein synthesis. 
Further evidence indicates that IL-8 triggers activation of AKT and its 
proximal target, S6K (Figures 15 and 16). This is consistent with the previous 
studies demonstrating IL-8/AKT/S6K-mediated upregulation of cyclin D1 protein 
synthesis [83, 102]. Active S6K directly stimulates protein translation via 
phosphorylation of ribosomal S6 protein. S6K is also known to be activated by 
mTOR [102]. Interestingly, we did not observe an increase in the active form of 
mTOR, phospho-mTOR-S2448, when Calu-3 or primary airway epithelial cells 
were treated with IL-8 (data not shown). Whether alternative activated forms of 
mTOR, such as phospho-mTOR-S1261 [103], or other potential players, such as 
PDK1 [104], might be involved in S6K activation are currently under investigation.  
In addition, we demonstrate for the first time that IL-8 signaling results in the 
inhibition of GSK3β, as determined by the increase in phospho-GSK3β-S9 protein 
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(Figure 18). GSK3β is a ubiquitously expressed constitutively active 
serine/threonine kinase that regulates multiple signaling pathways, such as gene 
transcription, protein translation, cell-cycle regulation, and apoptosis [105]. Our 
data indicate that GSK3β negatively regulates CAREx8 expression and is consistent 
with our previous studies [20]. GSK3β is known to regulate protein translation by 
modulating the activity of eIF2B, a guanine nucleotide exchange factor for a protein 
translation initiation factor, eIF2 [85-87]. The results of this study, however, do not 
address the possibility of an indirect effect that may result from the inhibition of 
AKT/S6K or GSK3β, which is a limitation in this study. 
We propose a model through which the protein levels of CAREx8 are 
stimulated by IL-8 and this model summarizes our results (Figure 21). Treatment 
of airway epithelial cells with IL-8 results in the activation of AKT which has two 
differential downstream targets: 1) S6K, which is activated, and 2) GSK3β, which 
is inactivated [91, 106]. Both these signaling proteins culminate in augmenting de 
novo CAREx8 protein synthesis and in turn susceptibility to adenoviral infection. 
The reason why one external stimulus differentially activates two pathways is not 
clear. However this is not an uncommon phenomenon. For example, 
coxsackievirus binding at the apical surface of gut epithelial cells is shown to 
activate Abl and Fyn kinase differentially and both of these signaling proteins, and 
their respective pathways, are crucial for the efficient infection of polarized gut 
epithelial cells by group B coxsackieviruses [16].  
Why are CAREx8 levels increased at the apical epithelial cell surface in 
response to IL-8? I hypothesize that CAREx8 localizes at the apical surface of 
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epithelial cells to retain leukocytes, such as neutrophils, in the region of 
inflammation by interacting with the leukocyte-specific junctional adhesion 
molecule-like protein (JAML). The basolateral CAR-JAML interaction is for efficient 
neutrophil transmigration [43, 44]. Upregulated apical CAREx8 may retain infiltrating 
neutrophils in the region of inflammation and limiting distant, spurious 
inflammation. The following aim is focused on testing the hypothesis that CAREx8 
tethers neutrophils at the epithelial apical cell surface.  
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Chapter 4: CAREx8 tethers infiltrating neutrophils at the epithelial apical 
surface 
The data presented so far demonstrates that exposure of an airway epithelium to 
IL-8 stimulates CAREx8 protein levels in the cell and at the apical surface of the 
epithelium. Adenovirus is then able to take advantage of increased apical CAREx8 
to efficiently enter the airway epithelium. However, why would the cell increase 
CAREx8 levels in response to IL-8 stimulation if it might be detrimental for the cell? 
One possible answer to this question is that CAREx8 might be crucial for an innate 
function. It is well accepted that viruses have evolved to exploit essential proteins 
and cellular biology to enhance infection and survival of the virus. It is likely that 
invading adenovirus has simply taken advantage of an important physiological cell 
function in order to gain entry into the epithelium. By exploiting an evolutionary 
conserved physiological function, adenovirus has found a niche that the host has 
not eliminated through natural selection. We hypothesize that the endogenous 
function of CAREx8 in a polarized epithelium is to tether infiltrating 
neutrophils at the apical surface of polarized airway epithelial cells. 
This hypothesis was tested through three specific aims: 
4.1. To generate stable MDCK cells expressing inducible human CAREx8, 
human CAREx7, or m-Cherry. 
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4.2. To show that CAREx8 mediates neutrophil adhesion at the epithelial 
apical surface. 
4.3. To show that infiltrating neutrophils adhere to the apical surface in a 
CAREx8 dependent manner 
4.1. Generation of stable MDCK cells expressing inducible human CAREx8, 
or human CAREx8, or m-Cherry. 
 
4.1.1. Rationale:  
I hypothesized that CAREx8 mediates neutrophil adhesion at the epithelial cell 
surface. If this hypothesis is true, then increasing the cellular apical levels of 
CAREx8 will increase neutrophil adhesion at the apical cell surface. To test this, we 
developed MDCK cells that stably express human CAREx8 under the regulation of 
a doxycyclin (DOX) inducible promoter. This system enables the manipulation of 
the levels of CAREx8 expressed within an established epithelium. Additionally, 
control cells stably expressing either human CAREx7 or the red fluorescent protein, 
m-Cherry, were also developed.  
4.1.2. Results: 
Inducible MDCK stable cells expressing CAREx7or CAREx8, or mCherry 
MDCK cells were chosen because these cells are well characterized, grow fast, 
and most importantly, polarize rapidly into an epithelium with the expected 
distribution of cellular proteins. To generate MDCK stable cells, cells were first 
infected with lentivirus carrying the Tet-on gene that is required for inducible 
expression from the pLVX-tight-puro promoter. Clonal cell lines from single cells 
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were compared to the parental MDCK to identify the Tet-on cell line most similar 
to parental. This MDCK-Tet-on cell line was the parental cell line for creating the 
Dox-inducible pLVX-tight-puro cell lines carrying the gene encoding FLAG-tagged 
human CAREx7, or FLAG-tagged human CAREx8, or m-Cherry. Clones from single 
cells stably expressing Dox-inducible CAREx8, CAREx7 and mCherry were selected 
and expanded. These clones are from now on referred to as either MDCK-CAREx8, 
MDCK-CAREx7, or MDCK-mCherry cells.  The stable integration of CAREx8, 
CAREx7, or m-Cherry was confirmed using PCR (Figure 22). The primers used in 
the PCR analysis of DNA from these cells were specific to exogenous CAREx8 or 
CAREx7, respectively, and did not detect the endogenous gene.  To accomplish 
this specificity, the forward and the reverse primer used to detect exogenous 
CAREx7 overlapped the junction between exon 6 and exon 7 for the upstream 
primer while the downstream primer was in the CAREx7-specific sequence. PCR 
for CAREx8 used the same upstream primer but the downstream primer overlapped 
the splice site between exon 7 and exon 8.  Using such primers eliminates the 
possibility of detecting the endogenous CAREx7 or CAREx8 gene in which the exons 
are interspersed with long introns. Several clones positive for the exogenous 
expression of CAREx7, CAREx8, or mCherry respectively were expanded and 
subjected to further characterization.  
Characterization of MDCK- CAREx7, CAREx8 and mCherry 
The clones were chosen on the basis of their ability to form junctions, polarize into 
an epithelium and be infected by adenovirus. These properties of the MDCK stable 
cells in the absence of DOX was compared to the parental MDCK cell line. Of the 
77 
 
multiple different colonies and clones picked for gene, MDCK-CAREx8 clone #1, 
MDCK-CAREx7 clone #3, and MDCK-mCherry clone #1 were chosen after careful 
characterization and comparison with the parental MDCK (data not shown) in the 
absence of DOX. We analyzed the exogenous expression of CAREx8 and CAREx7 
in the presence of increasing concentration of DOX using WB analysis (Figure 
23A). We observed that with increasing concentration of DOX there was a dose-
dependent increase in the expression of FLAG-CAREx8 and CAREx7. In addition, 
apical surface-specific biotinylation was performed and we observed a dose-
dependent increase in the apical localization of CAREx8 (Figure 23B). In contrast, 
in the presence of DOX we observed little or no CAREx7 at the apical surface, as 
predicted.  
MDCK-CAREx8 shows an increased susceptibility to adenovirus infection.  
To characterize the susceptibility of the polarized MDCK stable cells to adenovirus 
infection, cells were polarized and infected with Ad5-β-Gal from the apical surface. 
Consistent with the WB, we observed a rapid dose-dependent increase in 
adenoviral entry for the MDCK-CAREx8 stable cell line followed by a plateau in viral 
transduction (Figure 23C) and viral genomes (Figure 23D).  This cell line had a 2-
8 fold increase in adenoviral entry, as measured by viral genomes, when compared 
to MDCK-CAREx7 and mCherry stable cells. This data strongly suggests that 
CAREx8 increased the polarized airway epithelial cell susceptibility to adenoviral 
infection. This property is attributed to the apical localization of CAREx8 since 
MDCK-CAREx7 did not show any significant difference when compared to the 
control MDCK-mCherry cells. These experiments confirmed the successful 
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development of MDCK stable cells that express DOX inducible FLAG-CAREx8, 
FLAG-CAREx7, and mCherry. These stable cell lines were critical for many of the 
remaining experiments in my thesis.   
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Figure 22: MDCK cells that have stably incorporated m-Cherry, CAREx7, or CAREx8 
exogenous tet-inducible genes. The DNA isolated from the MDCK-mCherry, MDCK-
CAREx7 and MDCK-CAREx8 cells was PCR amplified to determine the presence of stably 
incorporated mCherry, CAREx7 and CAREx8 DNA, respectively.  
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Figure 23: Doxycycline dose response in MDCK cells stably expressing DOX-
inducible CAREx8, CAREx7, or mCherry polarized epithelia. A) Increasing DOX 
increases CAREx8 or CAREx7 protein levels but not actin. B) Apical-surface selective 
biotinylation of CAREx8 and CAREx7 shows the presence of FLAG-tagged CAREx8 but not 
CAREx7. C) MDCK stable cells treated with increasing DOX shows a dose-dependent 
increase in apical Ad-β-Gal activity (which correlates with viral transduction) and D) viral 
genomes (Vg), (which correlates with the amount of viral entry). The dramatic increase is 
not seen in the MDCK-CAREx7 cells and the negative control MDCK-mCherry cells. 
Statistical significance was evaluated using one-way ANOVA *P<.05.  
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4.2. CAREx8 mediates neutrophil adhesion at the epithelial apical surface. 
4.2.1. Rationale:  
Unlike CAREx7, which localizes basolaterally, the CAREx8 isoform localizes apically 
in polarized airway epithelial cells. Zen et al., 2005 showed that blocking the 
basolateral CAR-JAML interaction reduces the rate of neutrophil transmigration by 
50% [44]. JAML has been shown to interact with CAR at its extracellular D1 
domain. The CAR D1 domain is identical between the CAREx7 and CAREx8 
isoforms. Therefore, I hypothesized that while CAREx7 is crucial for neutrophils 
migrating through the paracellular space, CAREx8 tethers neutrophils at the 
epithelial cell surface. Therefore, I further hypothesized that increasing CAREx8 
expression should promote neutrophil adhesion at the epithelial apical surface. 
The CAR-JAML interface overlaps with the region where CAR interacts with Ad 
FK. Thus, blocking CAR using Ad FK will further confirm CAREx8 mediated 
adhesion of neutrophils at the epithelial apical surface. As shown earlier, IL-8 
stimulates CAREx8 protein expression and apical localization. Therefore, we 
predicted that treatment of airway epithelial cells with IL-8 would stimulate 
neutrophil adhesion at the epithelial apical surface.  
4.2.2 Results:  
MDCK-CAREx8 tethers neutrophils at the epithelial apical surface.  
MDCK-CAREx8, CAREx7 and mCherry cells were polarized on a tissue culture dish 
and induced with increasing concentrations of DOX for 24 H to enable dose-
dependent increase in the expression of the exogenous genes. This was followed 
by a neutrophil adhesion assay using freshly isolated, fluorescently labelled 
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neutrophils from the peripheral blood of healthy donors. Increasing the CAREx8 
protein levels in MDCK-CAREx8 cells correlated directly with increased neutrophil 
adhesion on the epithelial cell surface in a dose-dependent manner (Figure 24). In 
contrast, the MDCK-CAREx7 and mCherry cells only showed a baseline neutrophil 
adhesion both in the presence and absence of DOX (Figure 24). This data 
suggests that MDCK-CAREx8 cells tether neutrophils at the epithelial cell surface.  
Neutrophil adhesion is CAREx8 mediated: 
It is hypothesized that MDCK-CAREx8 tethers neutrophils at the apical surface via 
CAREx8-mediated interaction. To directly test this hypothesis, the Ad5 FK was used 
to outcompete the putative interaction between epithelial apical CAREx8 and 
neutrophil JAML. Ad5 FK specifically binds to CAR to attach to the host cell and 
although the binding site overlaps the CAR-CAR and CAR-JAML binding sites, the 
CAR-FK affinity is 1000 and 500 times greater, respectively.  CAREx8 was first 
blocked with purified Ad5 FK in polarized MDCK-CAREx8 cells that were either not 
induced or induced with DOX for 24 H. Fluorescently-labeled neutrophils were 
added to the apical surface and allowed to bind in the presence or absence of Ad5 
FK for 15 min. In the presence of increasing Ad5 FK, there was a dose-dependent 
decrease in neutrophil adhesion (Figure 25). Moreover there was complete knock 
down of neutrophil adhesion at the highest Ad5 FK concentration (192 ug, nearly 
106 times greater Ad5 FK than the predicted number of CAR receptor on the 
epithelial cell surface of uninduced cells) that was used. In contrast, the neutrophil 
adhesion could not be blocked in the presence of Ad3 FK, a control group B Ad 
that does not bind to CAR as the primary receptor (Figure 24). The primary 
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receptor for Ad3 is desmoglein 2 [107]. These data strongly suggest that CAREx8 
tethers neutrophils at the apical epithelial cell surface. 
IL-8 treatment of primary airway epithelial cells allows increased neutrophil 
adhesion on the apical surface of the Calu-3 cells. 
I have previously shown that the treatment of both Calu-3 cells and primary airway 
epithelial cells with IL-8 stimulates CAREx8 at the epithelial apical surface with little 
or no effect on the basolateral CAREx7 protein levels. Thus, to confirm that IL-8-
induced CAREx8 mediates neutrophil adhesion, we performed neutrophil adhesion 
assays on Calu-3 cells treated with IL-8 for 4 H. We observed that IL-8 treatment 
resulted in a significant increase in neutrophil adhesion (Figure 26).  
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Figure 24: CAREx8 tethers neutrophils at the epithelial apical surface. Neutrophil 
adhesion assays were performed on DOX induced stable cells A) MDCK-CAREx8, B) 
MDCK-CAREx7, and C) MDCK-mCherry cells. Neutrophils (green) that adhered to the 
epithelial apical surface were imaged. Each panel is a representative image of the 
respective DOX concentrations used in this experiment.  
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Figure 25: CAREx8 tethers neutrophils at the epithelial apical cell surface. A) MDCK-
CAREx8 either uninduced or induced with DOX were treated with increasing concentrations 
of Ad5 FK (gray bars) or 640 ug/ml Ad3 FK (black bars). Neutrophil adhesion assays were 
performed with the freshly isolated, fluorescently labelled neutrophils. The adhered 
neutrophils were imaged and the fluorescence intensity was quantitated. Fold changes in 
the fluorescence intensity in comparison to uninduced and untreated controls are shown. 
Statistical significance was evaluated using one-way ANOVA and Bonferroni post hoc test. 
*P<.05, ** P<.01 and ***P<.001 
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Figure 26: IL-8 treatment in Calu-3 cells increases neutrophil adhesion. IL-8 
treatment in Calu-3 cells increases neutrophil adhesion. A) Calu-3 cells were either 
uninduced or induced with IL-8 30 ng/ml for 4 H. Post-treatment a neutrophil adhesion 
assay was performed. Bound neutrophils were imaged and B) quantitated using 
MetaMorph software. Statistical significance was evaluated using student t test, ***P<.001 
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4.3. Infiltrating neutrophils adhere to the apical surface in a CAREx8 
dependent manner 
4.3.1. Rationale:  
Section 4.2 indicates that CAREx8 is able to tether neutrophils at the epithelial cell 
surface. However, in vivo, the neutrophils migrate from the basal surface of the 
epithelium, through the paracellular space and finally to the apical surface. At the 
apical surface the neutrophils remain adhered before detaching into the lumen of 
the airway. Therefore, I asked whether CAREx8 can tether the infiltrating neutrophils 
that transmigrate through the epithelium space to the apical surface in a 
physiologically relevant polarized basal to apical surface model system. Based on 
the results above it is predicted that CAREx8 will adhere the infiltrating neutrophils 
at the epithelial apical surface. On the other hand, because CAREx7 is shown to be 
important for neutrophil transmigration [44], it is predicted that overexpressing 
CAREx7 will promote neutrophil transmigration across the epithelium CAREx7. It is 
also expected that induced mCherry cells will remain similar to baseline. 
4.3.2. Results: 
CAREx8 tethers infiltrating neutrophils at the epithelial cell surface.  
To determine the fate of infiltrating neutrophils in the presence of increased CAREx8 
concentrations, I performed a neutrophil transmigration assay (Figure 27). After 
allowing the neutrophils to migrate, 2 populations of cells were quantitated 1) 
neutrophils that completely transmigrated through the paracellular space and had 
entered the apical lumen (the outer well in the model system (Figure 27) and 2) 
neutrophils that remain adhered to the epithelial apical surface. I observed that 
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DOX treatment induced neutrophil adhesion at the apical surface of MDCK-CAREx8 
cells (Figure 28C). However there was no change in neutrophil transmigration 
(Figure 28D). In contrast, Dox treatment induced neutrophil transmigration across 
the polarized epithelium of MDCK-CAREx7 cells without affecting neutrophil 
adhesion on the apical surface (Figure 28F). Neutrophil adhesion at the epithelial 
apical surface was not affected in MDCK-CAREx7 cells (Figure 28E).  The MDCK-
mCherry cells that served as a negative control had baseline neutrophil adhesion 
and migration (Figure 28A and B). 
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Figure 27: A model showing the system used for neutrophil transepithelial 
migration. The system contains an outer well with a millicell placed inside. The epithelial 
cells are polarized in an inverted fashion such that the apical surface is facing the bottom 
of the outer well. Fluorescently labelled neutrophils are chemically (chemoattractant) 
driven to transmigrate from the basal to the apical surface. After transmigration, 
neutrophils that remain adhered to the epithelial cells and those that transmigrated to the 
bottom of the outer well were quantitated. 
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Figure 28: CAREx8 tethers infiltrating neutrophils at the apical surface of the 
polarized epithelium. Neutrophil transmigration assays were performed in a 
physiologically relevant manner (basal to apical surface) in (A, B) MDCK-mCherry, (C, D) 
MDCK-CAREx8 and (E, F) MDCK-CAREx7 cells that were either uninduced or induced with 
DOX. % neutrophil adhesion (A, C, E) and % neutrophil transmigration (B, D, F) were 
quantitated by measuring the fluorescent intensity using metamorph software. Statistical 
significance was evaluated using student t test, *P<.05, **P<.01 
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4.4. Discussion 
Upon pathogenic encounter, neutrophils are the first amongst the immune 
cells to arrive at the site of inflammation or infection. Neutrophils transmigrate 
through the endothelium into the interstitium and finally arrive at the airway lumen 
via transepithelial migration. Subsequently, via a combination of enzymatic and 
cytotoxic events, neutrophils aid in the clearance of pathogens. Therefore 
neutrophil transmigration is an important phenomenon in the innate immune 
response of the host. Deficiency in the neutrophil recruitment leads to several 
diseased conditions, such as LAD-1, and predisposal to infections  [49]. On the 
other hand, uncontrolled neutrophil transepithelial migration and accumulation at 
the mucosal surface of the airway or gut is a hallmark of inflammatory diseases. 
For example, the accumulation of neutrophils in the alveolar space and intestinal 
crypts is observed in cystic fibrosis and inflammatory bowel diseases, respectively. 
The severity of the inflammatory disease directly correlates with the extent of PMN 
accumulation. Based on the type of cytokine present, different leukocytes are 
recruited. Monocyte Chemotactic Protein (MCP1), Macrophage Inflammatory 
Protein 1 alpha (MIP1α), and Regulated on Activation, Normal T cell Expressed 
and Secreted (RANTES; aka CCL5) recruit monocytes, T cells, natural killer cells, 
and eosinophils [108]  The proinflammatory cytokine IL-8 recruits neutrophils 
preferentially [109].  
The process of neutrophil transepithelial migration compels the constant 
formation and destruction of interactions between the neutrophil and the 
epithelium. After extravasation from the blood vessel and migration through the 
92 
 
interstitial tissues, it begins with the adhesion of neutrophils to the epithelial basal 
surface, followed by migration through the paracellular pathway, ultimately arriving 
at the apical surface (Figure 4). The different proteins that are involved in 
neutrophil adhesion at the apical surface and the importance of these molecules 
are finally being identified. For example, proteins, such as CD44 and DAF, are 
crucial for the detachment of neutrophils into the gastrointestinal lumen [58, 59]. 
However, less is known about neutrophil adhesion and detachment in the airway.  
For the first time, a novel biological function for CAREx8 is described in this 
study. It has been shown that IL-8 augments apical CAREx8 expression in polarized 
airway epithelia (Figures 7, 9, 11). In addition, apically localized CAREx8 can tether 
neutrophils (Figure 24). This is supported by the finding, that blocking CAREx8 
using adenovirus type 5 FK completely inhibits neutrophil adhesion, underscoring 
the importance of CAREx8 in tethering neutrophils (Figure 25). Interestingly IL-8 
treatment of airway epithelia increased neutrophil adhesion (Figure 26). Since it is 
proven that IL-8 stimulates CAREx8 expression, it is very likely that IL-8 stimulated 
neutrophil adhesion might be via CAREx8.  Moreover, apical CAREx8 proves to be 
adhesive for infiltrating neutrophils, without grossly affecting neutrophil 
transmigration (Figure 28). It was also observed that CAREx7, which localizes at 
the basolateral surface of polarized epithelia, promotes neutrophil transmigration 
but not apical adhesion (Figure 28). This data is in agreement with the previous 
study that shows blocking basolateral CAR affects the rate of neutrophil 
transepithelial migration [44]. It is speculated that the difference in the function of 
the two isoforms of CAR is attributed to its localization within the epithelium. In 
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addition the fact that neutrophil transmigration is not affected in MDCK-CAREx8 
cells induced with DOX suggests that CAREx8 might not be involved in neutrophil 
transmigration.  
Considering these lines of evidence, it is envisioned that IL-8 secreted 
during a pathogenic intrusion sets off an innate immune response by recruiting 
neutrophils to the apical surface. At the same time, IL-8 also increases the 
expression and the apical localization of CAREx8, which serves to tether the 
recruited neutrophils. Adhesion of neutrophils to the epithelial apical surface could 
serve several essential biological functions such as: 1) To achieve the critical 
neutrophil concentration required for the efficient killing of invading pathogens; 2) 
To help maintain focused inflammation, thereby preventing unnecessary damage 
to the neighboring cells; 3) To form a defensive barricade that prevents further 
infection of the epithelium; and 4) To prevent neutrophils from being washed away 
into the airway lumen.  
Expression of ICAM-1 has been shown to be upregulated in response to 
IFN-γ and TNF-α in both airway [53] and gastrointestinal epithelium [10, 52]. Also, 
increased ICAM-1 expression is evident in CF [110] and inflamed intestinal 
mucosa [10]. ICAM-1 has been shown to tether neutrophils at the apical surface 
of both the airway [110] and the intestinal epithelium. However, blocking ICAM-1 
only partially reduced neutrophil adhesion suggesting the involvement of additional 
proteins [52, 110, 111]. Whether CAREx8 is involved in neutrophil tethering in the 
inflammatory diseases is yet to be determined. Uncontrolled secretion of 
proinflammatory cytokines, including IL-8 [110] and TNF-α, is evident in 
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inflammatory diseases. TNF-α, via activation of NFκB, is known to induce IL-8 
secretion [112]. Therefore, it is very likely that CAREx8 is involved in tethering 
neutrophils at the apical surface. In the future, it will be intriguing to determine how 
the expression of CAREx8 differs in pathological tissues from patients with CF 
compared to healthy tissue from the general population. 
Current therapeutic options for the treatment of chronic inflammation and 
neutrophilia in inflammatory diseases are largely ineffective [63, 110, 113-115]. A 
greater understanding of the mechanisms that govern neutrophilia is required in 
order to identify novel strategies and therapeutics for the treatment of excessive or 
prolonged neutrophil recruitment and retention. The vast majority of studies and 
therapeutic approaches have focused on neutrophils to combat neutrophilia. In 
contrast, tissue-targeted approaches may yield improved disease-specific 
therapeutics with fewer side effects. Therefore, there is a pressing need for the 
elucidation of various adhesive interacting partners and the mechanism underlying 
PMN retention at the epithelial apical surface. This will further enable the design 
of organ specific drugs for the treatment of inflammatory diseases. Thus, the 
findings of this study have direct implications in the development of interventions 
for the treatment of inflammatory diseases.   
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Chapter 5: Neutrophils tethered to the airway epithelial cell surface benefit 
adenovirus entry 
Background:  Currently there are no specific treatments for adenovirus infection 
and supportive care is insufficient. Particularly in military recruits, pediatric 
patients, and in immunocompromised individuals, adenovirus infection can cause 
fatal respiratory distress. Several studies have shown that for infants and adults 
with bronchitis and lower respiratory tract infections, adenovirus contributes to 
about 5-15% of total viral infections [116-120]. In a study conducted by Gem et al., 
adenovirus, detected either as a sole pathogen or in combination with other 
respiratory virus, accounts for nearly 20% of the viral infections in infants in urban 
areas, who are at a higher risk for wheezing illness and asthma [99].  
Although many contributing factors, such as demographic characteristics, 
environmental factors, and allergen exposure, may influence the development of 
asthma, exposure to viral pathogen is also a critical factor for the development of 
asthma. In particular adenovirus infection is of interest because early exposure to 
the virus can further the development of asthma [121]. The development and 
severity of COPD has also been associated with adenovirus infections [21, 122]. 
In CF, the factors that modulate viral infection remain elusive. CF is characterized 
by accumulation of neutrophils at the epithelial apical surface. The 
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accumulation of neutrophils is detrimental to the epithelium. The reactive oxygen 
species generated by the neutrophils injure the surrounding tissue [123]. 
Therefore, I hypothesized that neutrophils adhered at the epithelial apical surface 
will augment adenoviral infection.  
This hypothesis will be tested by 2 aims: 
5.1. To test if neutrophils tethered on the epithelial apical surface augment 
adenoviral infection 
5.2 To test if neutrophil adhesion alters transepithelial resistance 
5.1. Neutrophils tethered on the epithelial apical surface increase the 
susceptibility of the epithelium to adenoviral infection 
 
5.1.1. Rationale:  
In the previous aim I demonstrated that CAREx8 tethers neutrophils at the epithelial 
apical cell surface. In vivo this function of CAREx8 might be essential because the 
adhered neutrophils form a defense barricade at the apical surface that is very 
important in normal healthy individuals. However, under pathological conditions 
the neutrophils that have accumulated at the epithelial apical surface might cause 
damage to surrounding tissue as a result of the chemicals released by the 
neutrophils. Therefore it is hypothesized that adhered neutrophils at the apical 
surface of the epithelium will aid in adenoviral infection.  
5.1.2. Results: 
Tethered neutrophils augment viral entry in polarized epithelia. 
97 
 
In order to understand the contribution of neutrophils to viral infection, a neutrophil 
adhesion assay was performed with increasing concentrations of neutrophils (0 – 
1 X 107) on polarized uninduced or induced MDCK-CAREx8 cells. The unbound 
neutrophils were washed off and the epithelia (with neutrophils adhered on the 
apical surface) were infected with adenovirus for 1 H, washed, and returned to the 
incubator. 24 H post infection, cells were lysed and viral entry was quantitated 
using qPCR analysis for viral genomes (vg). Consistent with the hypothesis I 
observed a significant 2-3 fold increase in adenoviral entry when more adhered 
neutrophils were present (Figure 29). Adenoviral entry was increased by an 
additional 2-fold when this same neutrophil adhesion assay was performed on 
MDCK-CAREx8 cells treated with DOX (Figure 29). This latter effect is attributed to 
increase in CAREx8 that is induced upon DOX treatment.  
Next we used an alternate approach to test the hypothesis. A neutrophil adhesion 
assay was performed with one constant concentration of neutrophils on MDCK-
CAREx8 cells, which were either induced or not induced with DOX. Post neutrophil 
adhesion, these epithelial cells were infected with increasing MOI of Ad5-β-Gal 
(Figure 30). To determine the baseline infection, uninduced MDCK-CAREx8 cells 
having no neutrophils were infected with increasing Vg. Interestingly, we observed 
that in the presence of neutrophils there was a significant 3-10 fold increase in 
adenoviral entry that was further amplified by at least 3 fold in the presence of DOX 
(Figure 30). In the case of uninduced MDCK-CAREx7 (Figure 31) and mCherry cells 
(Figure 32) there was a significant increase in adenovirus entry in the presence of 
neutrophils as observed in the uninduced  
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Figure 29: Doxycycline induction promotes adenoviral infection in MDCK-CAREx8 
cells in the presence of adhered neutrophils. MDCK-CAREx8 cells were either 
uninduced (white bars) or induced (shaded bars) with DOX. A neutrophil adhesion assay 
was performed with increasing number of neutrophils as indicated in the figure. Post 
neutrophil adhesion, the MDCK-CAREx8 cells were infected with Ad5-β-Gal for 1 H. 24 H 
later, viral entry was determined by quantitating viral genomes (Vg) using qPCR analysis. 
Fold change in viral genome entry is shown. Statistical significance was evaluated using 
one way ANOVA and Dunnetts post hoc test, *P<.05, **P<.01, ***P<0.001.  
 
0
2
4
6
8
0 0.5 1 2 5 10 0 0.5 1 2 5 10
Neutrophils (X106)
* ** *** *** **
* ** ** *0 ng DOX
200 ng DOX
F
o
ld
 c
h
a
n
g
e
 i
n
 v
ir
a
l 
g
e
n
o
m
e
s
99 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Neutrophils adhered on the apical surface of the epithelial cells promote 
adenoviral entry. Adenovirus entry was quantitated by qPCR analysis in uninduced 
MDCK-CAREx8 cells (circle) and compared with uninduced MDCK-CAREx8 cells with 
adhering neutrophils (square) and DOX induced MDCK-CAREx8 cells with adhering 
neutrophils (triangle). Statistical significance was evaluated using one way ANOVA and 
Bonferroni post hoc test, *P<.05, **P<.01,  
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Figure 31: Neutrophils enhance adenovirus entry into polarized epithelia but 
CAREx7 does not. Adenovirus entry was quantitated by qPCR analysis in uninduced 
MDCK-CAREx7 cells (circle) and compared with uninduced MDCK-CAREx7 cells with 
adhering neutrophils (square) and DOX induced MDCK-CAREx7 cells with adhering 
neutrophils (triangle). DOX induced MDCK-CAREx7 cells with adhered neutrophils had 
the greatest adenovirus susceptibility  
 
0.1 1 10 100 1000
0.1
1
10
100
1000
10000
100000
MOI PFU/ml
F
o
ld
 c
h
a
n
g
e
 i
n
 v
ir
a
l 
g
e
n
o
m
e
s
MDCK-CAREx7
101 
 
 
 
 
 
 
 
 
 
Figure 32: Neutrophils enhance adenovirus entry into polarized epithelia but 
mCherry and Dox treatment does not. Adenovirus entry was quantitated by qPCR 
analysis in uninduced MDCK-mCherry cells (circle) and compared with uninduced MDCK-
mCherry cells with adhering neutrophils (square) and DOX induced MDCK-mCherry cells 
with adhering neutrophils (triangle). DOX induced MDCK-mCherry cells with adhered 
neutrophils had the greatest adenovirus susceptibility. Statistical significance was 
evaluated using one way ANOVA and Bonferroni post hoc test, *P<.05, ***P<.001,  
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MDCK-CAREx8 cells, yet there was no significant difference in the presence of 
DOX. This data strongly suggests that neutrophils increase adenoviral entry and 
the presence of increased CAREx8, which results in increased neutrophil adhesion, 
is further amplified.  
5.2. Neutrophil adhesion does not decreases transepithelial resistance 
5.2.1. Rationale:  
The previous experiments do not indicate how neutrophils promote adenoviral 
infection. Previous studies have shown that neutrophil adhesion at the apical 
surface of the gut epithelium increased the epithelial cell paracellular permeability 
in order to promote neutrophil transmigration. There are two measures of epithelial 
permeability 1) the ability for a current to move through the epithelium, which can 
be measured by transepithelial resistance, and 2) the ability of small substances 
to migrate within the paracellular space through the tight junctions and between 
adjacent cells. Both of these measures frequently correlate, therefore, I first sought 
to determine the transepithelial resistance in the presence of apically adhered 
neutrophils.  
5.2.2. Results:  
Neutrophil adhesion at the epithelial apical surface does not decrease the 
transepithelial resistance   
Neutrophil adhesion assay was performed on polarized MDCK-CAREx8 cells that 
were either uninduced or induced with DOX. Polarized epithelia with bound 
neutrophils were submerged and TER measured. Interestingly, we did not observe 
a decrease in the transepithelial resistance when compared to MDCK- 
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Figure 33: Neutrophil adhesion does not decrease the transepithelial resistance of 
MDCK-CAREx8 cells. TER was measured in MDCK-CAREx8 cells that were not induced 
with or without neutrophils or DOX-induced MDCK-CAREx8 cells with tethered neutrophils 
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CAREx8 without apically adhered neutrophils (Figure 33). Although there was a 
trend towards increased TER, this was not significant by one-way ANOVA. 
5.3. Discussion:  
 In this study we have demonstrated a novel function for the apical 
adenoviral receptor, CAREx8. CAREx8 tethers the infiltrating neutrophils at the 
epithelial apical surface. Although neutrophils are critical for fighting invading 
pathogens, the importance of apically adhered neutrophils is not yet well 
established. It is speculated that under physiological conditions, the apically 
adhered neutrophils are crucial to enable a close encounter with, and ultimately 
eradication of, the pathogen. For example, it is known that a threshold number of 
neutrophils are required to eradicate bacteria [124, 125]. However, apical 
neutrophil adhesion may be detrimental under pathological conditions. 
Accumulation of neutrophils at the epithelial cell surface can cause adverse effects 
on the surrounding tissue.  These cells can release inflammatory cytokines which 
exacerbate the situation. In this study, I show yet another repercussion of 
accumulated neutrophils at the epithelial apical surface. I have demonstrated that 
neutrophils promote adenovirus entry into the airway epithelia, which is expected 
to further contribute to pathology (Figures 29 and 30). Taken together, our data 
suggests that the adenovirus may have evolved to co-opt the innate immune 
response of the host, which may have been initiated by the virus. In addition it is 
possible that under pathological conditions, such as CF, where excess neutrophils 
accumulate on the cell surface, the adenoviral entry may be further augmented. 
There could be several mechanisms by which the neutrophils might be promoting 
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viral infection. For example: 1) as shown with intestinal epithelial cells, it is possible 
that the apically adhered neutrophils, cause epithelial cell signaling which 
culminates in the loosening of the junctions to enable increased neutrophil 
recruitment. This is not likely given that there is no change in TER (Figure 32), 2) 
apically adhered neutrophils may themselves stimulate apical CAREx8 localization. 
While this would accommodate additional infiltrating neutrophils, adenovirus is 
able to take advantage of the additional receptors to enter the epithelium, 3) the 
apically adhered neutrophils may release inflammatory mediators that alter the 
fluid phase endocytosis that occurs at the apical surface. 4) Neutrophil-produced 
inflammatory mediators may alter epithelial barrier integrity. Future experiments 
will focus on elucidating the exact mechanism(s) behind enhance viral entry. 
Understanding this may lead to novel therapies to inhibit adenovirus infection or 
reduce the toxic effects of chronic inflammation.  
Rhinovirus, another viral respiratory pathogen, might be using a similar 
mechanism as adenovirus to enter into the host epithelial cell from the apical 
surface of epithelia.  Rhinovirus uses ICAM-1 to bind and enter airway epithelial 
cells. Similar to CAREx8, the apical expression and localization of ICAM-1 is 
regulated by TNF-α and IFN-γ. The expression of ICAM-1 is tightly regulated and 
usually kept very low. However, when the epithelium is exposed to TNF-α or IFN-
γ, ICAM-1 expression is augmented and focused at the apical surface where it can 
tether neutrophils. Rhinovirus that might have gained entry into airway can take 
advantage of this host response to enter the epithelium. Therefore, decoding the 
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mechanism of viral entry will help design novel interventions that may prevent the 
infections of other viruses, which currently have no specific treatments.  
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Chapter 6: Global Discussion 
CAR is the primary receptor for most adenovirus types. The apical isoform of CAR 
(CAREx8) is identical to the basolateral isoform of CAR (CAREx7) except for the C-
terminal 13 or 26 amino acids that are unique to CAREx8 or CAREx7, respectively. 
This seemingly minor difference in C-termini has a tremendous effect on the 
subcellular localization of the two isoforms. Understanding the molecular 
mechanism of apical CAREx8 regulation is important because both increasing and 
decreasing the concentration of apical viral receptor will have direct implications in 
the development of interventions for both augmenting adenoviral based vector 
entry and reducing susceptibility to wild type adenovirus in the event of an 
outbreak.  
IL-8 is a proinflammatory cytokine and neutrophil chemoattractant secreted 
at the time of pathogenic intrusion. IL-8 is secreted by the epithelium itself and by 
resident macrophages in the lung [126]. A polarized secretion of IL-8 at the 
epithelial apical surface generates the chemotactic gradient that facilitates 
neutrophil recruitment [127]. In this study, we show that IL-8 increases CAREx8 
expression and localization on the apical surface of Calu-3 cells as well as in 
primary human airway epithelia (Figures 7, 9 and 11). It is also demonstrated that 
IL-8, via differential activation of AKT/S6K (Figures 15 and 16) and inactivation of 
GSK3β (Figure 18), stimulates CAREx8 protein synthesis without altering mRNA 
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levels. While the pathway IL-8/AKT/S6K in CAR regulation is novel and exciting, 
the involvement of other signaling proteins in the pathway cannot be ruled out and 
is yet to be determined. This data suggested that CAREx8 might have a role in the 
host innate immune response. Therefore, I sought to determine the biological 
function of CAREx8. Neutrophils are typically found at the epithelial apical surface 
after the transmigrating through epithelial paracellular space. This is an essential 
step to obtain the critical neutrophil concentration required to clear invading 
pathogens and other pro-inflammatory molecules efficiently.  
Therefore, I hypothesized that apical CAREx8 tethers infiltrating neutrophils 
at the epithelial apical surface.  In agreement with the hypothesis, I was able to 
demonstrate that CAREx8 binds neutrophils at the apical surface (Figure 24). 
Moreover, CAREx8 adheres neutrophils infiltrating from the basolateral surface to 
the apical surface of the epithelium (Figure 28C and D). It was also demonstrated 
that IL-8 augments neutrophil adhesion coincident with stimulating CAREx8 apical 
localization (Figure 26). Additionally, previous studies have shown that CAREx7 
(basolateral CAR) interacts with neutrophil expressed JAML and that this 
interaction is important for the proper transmigration of neutrophils across the 
epithelium. In agreement with this, I have shown that overexpressing CAREx7 
stimulates neutrophil transmigration across the polarized epithelium (Figure 28E 
and F).  
Taken together, these data strongly suggest that a biological function of 
CAREx8 is to tether infiltrating neutrophils at the epithelial apical surface. The 
present study has found a novel function of CAREx8 as a mediator of the innate 
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immune response. While I found that this is an IL-8-mediated effect, it is also very 
likely that this might be a general mechanism used by other pro-inflammatory 
cytokines, such as IL-1 and IL-6, and opens a new area of research in the field.  
We next considered the fate of the invading adenovirus that may have 
gained entry into the airway. Adenovirus, via its protruding fiber knob, binds to CAR 
at the same extracellular region, which CAR uses to interact with JAML. Therefore 
I asked whether the apically bound neutrophils protect the epithelium from the 
invading adenovirus, or if invading adenovirus is able to outcompete the 
neutrophils for the extracellular binding site on CAREx8. Surprisingly, it was found 
that apically adhered neutrophils increased adenoviral entry (Figures 29 and 30).  
I first hypothesized that the neutrophils were destroying the tight junctions of the 
epithelium allowing the virus access to basolateral CAREx7. However, there was 
no drop in the transepithelial resistance of the polarized epithelium (Figure 33), an 
event that is required for the virus to access basolateral CAREx7. It could be 
possible that adhered neutrophil-mediated signaling at the apical surface 
stimulates CAREx8 apical localization, thus promoting infection. Therefore, it is 
important in the future to determine the exact mechanism of increased adenovirus 
entry.  
Taking all of these data together, it is envisioned that, IL-8 augments the 
expression of CAREx8 at the apical surface of the epithelia to tether the infiltrating 
neutrophils. However, if adenovirus happens to gain entry into the airway through 
a droplet, it can hijack the innate host immune response to gain entry into the cell 
by attaching to the CAREx8 recruited to the apical surface (Figure 34). Previously, 
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it was assumed that adenovirus must breach the barrier to access its primary 
receptor. My data provides a mechanism and an explanation as to how the virus 
might infect the intact epithelium without breaching the barrier. Under pathological 
conditions, like in the case of CF where resident bacterial biofilms constantly cause 
inflammation, this reaction might be amplified leading to secondary infection with 
the virus.  
A similar mechanism may be used by rhinovirus as well. Rhinovirus is the 
most common human cold virus. ICAM-1 is the primary receptor for rhinovirus 
[128]. The apical expression of ICAM-1 is induced by proinflammatory cytokines 
TNF-α and IFN-γ [10, 53]. ICAM-1 can tether neutrophils on the apical surface of 
both airway and intestinal epithelia [52, 110]. Different cytokines use different 
receptors to trigger cellular signaling cascades. Therefore, the kind of cytokine 
plays a critical role in the type of response initiated [129]. In the future it will be 
interesting to test if IL-8 has an effect on ICAM-1 and if TNF-α/IFN-γ can regulate 
the expression of CAREx8. It appears that both adenovirus and rhinovirus have 
evolved to take advantage of the innate immune response to other pathogens. 
CF is characterized by the accumulation of neutrophils at the mucus surface 
of the epithelium. Viral infections are one of the major causes for the exacerbation 
of CF and acute respiratory distress in CF patients [130]. My data suggests that 
the neutrophils accumulated at the apical surface favors adenoviral infection. Our 
study has generated a platform for understanding the mechanisms for viral 
infection in inflammatory diseases and could ultimately aid in the development of 
novel therapeutics for inflammatory diseases and to reduce viral-mediated 
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exacerbation of disease. Yet, there are many questions that remain to be 
answered, such as whether this scenario is observed in healthy individuals. If so, 
why do neutrophils promote adenoviral entry while they are for the protection of 
the host? One possible explanation could be that in vivo, the effect of IL-8 mediated 
increase in CAREx8 expression, localization, and adhesion of neutrophils is 
counteracted by other cytokines, or other factors, which are missing when using in 
vitro models. 
 Our lab is currently working on designing drugable peptides that can either 
increase or decrease the expression of CAREx8 at the apical surface of polarized 
epithelium. In future, we hope to test these peptides for their ability to augment or 
reduce the epithelial susceptibility to adenoviral infection and retain, recruit or 
release neutrophils, based on patient needs. 
 
 
  
112 
 
   
Figure 34: Schematic for the evolution of apical adenovirus infection 1) pathogenic 
invasion of the airway causes 2) both the resident macrophages and the epithelial cells to 
secrete IL-8. 3) IL-8 augments the protein synthesis and apical localization of CAREx8. 4) 
In addition, IL-8 also recruits neutrophils that transmigrate through the epithelium from the 
basal surface to the apical surface.  5) On the epithelial apical surface, the neutrophils 
adhere in a CAREx8 dependent manner.  6) At the same time, adenovirus that has gained 
entry into the airway can hijack the host innate immune response to gain entry into the 
host cell. TJ – Tight junction 
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